{"protocolSection":{"identificationModule":{"nctId":"NCT01059617","orgStudyIdInfo":{"id":"113483"},"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults","officialTitle":"A Study to Evaluate Immune Responses Following A/California/7/2009 (H1N1)V-like Virus Vaccination Given 4 Months Following Seasonal Influenza Vaccination in Adults 19 to 40 Years of Age"},"statusModule":{"statusVerifiedDate":"2018-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2010-02-09","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2011-01-14","type":"ACTUAL"},"completionDateStruct":{"date":"2011-10-21","type":"ACTUAL"},"studyFirstSubmitDate":"2010-01-28","studyFirstSubmitQcDate":"2010-01-28","studyFirstPostDateStruct":{"date":"2010-02-01","type":"ESTIMATED"},"resultsFirstSubmitDate":"2012-01-31","resultsFirstSubmitQcDate":"2012-05-03","resultsFirstPostDateStruct":{"date":"2012-06-07","type":"ESTIMATED"},"lastUpdateSubmitDate":"2018-07-04","lastUpdatePostDateStruct":{"date":"2018-08-20","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"This study is designed to characterize the safety and immunogenicity of a' pandemic influenza (H1N1) candidate vaccine GSK2340274A in adults 19 to 40 years who have never received influenza vaccination."},"conditionsModule":{"conditions":["Influenza"],"keywords":["Pandemic","GSK Bio's influenza vaccine GSK2340274A","H1N1","Influenza"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":133,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Flulaval/Arepanrix Group","type":"EXPERIMENTAL","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","interventionNames":["Biological: GSK Biologicals' FluLaval®","Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A"]},{"label":"Flulaval/Unadjuvanted Arepanrix Group","type":"EXPERIMENTAL","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","interventionNames":["Biological: GSK Biologicals' FluLaval®","Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A"]},{"label":"Placebo/Arepanrix Group","type":"EXPERIMENTAL","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","interventionNames":["Biological: Placebo (saline)","Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A"]},{"label":"Placebo/Unadjuvanted Arepanrix Group","type":"EXPERIMENTAL","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","interventionNames":["Biological: Placebo (saline)","Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A"]}],"interventions":[{"type":"BIOLOGICAL","name":"GSK Biologicals' FluLaval®","description":"Intramuscular injection","armGroupLabels":["Flulaval/Arepanrix Group","Flulaval/Unadjuvanted Arepanrix Group"]},{"type":"BIOLOGICAL","name":"Placebo (saline)","description":"Intramuscular injection","armGroupLabels":["Placebo/Arepanrix Group","Placebo/Unadjuvanted Arepanrix Group"]},{"type":"BIOLOGICAL","name":"GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A","description":"Intramuscular injections","armGroupLabels":["Flulaval/Arepanrix Group","Placebo/Arepanrix Group"]},{"type":"BIOLOGICAL","name":"GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A","description":"Intramuscular injections","armGroupLabels":["Flulaval/Unadjuvanted Arepanrix Group","Placebo/Unadjuvanted Arepanrix Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Seroconverted Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Seroconversion rate (SCR) was defined as the number of subjects who have either a pre-vaccination reciprocal HI titer \\< 10 and a post-vaccination reciprocal titer ≥ 40, or a pre-vaccination reciprocal HI titer ≥ 10 and at least a 4-fold increase in post vaccination reciprocal titer against the vaccine virus.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Number of Seroprotected Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Seroprotection rate (SPR) was defined as the number of subjects with H1N1 reciprocal HI titers ≥ 40 against the tested vaccine virus.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Seroconversion Factor for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Geometric mean fold-rise (GMFR), or seronversion factor (SCF), was defined as the geometric mean of the within-subject ratios of the post-vaccination reciprocal HI titer to the pre-vaccination reciprocal HI titer for the vaccine virus.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 122 to Day 164)."},{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Number of Seroconverted Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Seroconversion rate (SCR) was defined as the number of subjects who have either a pre-vaccination reciprocal HI titer \\< 1:10 and a post-vaccination reciprocal titer ≥ 1:40, or a pre-vaccination reciprocal HI titer ≥ 10 and at least a 4-fold increase in post vaccination reciprocal titer against the vaccine virus.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Number of Seroprotected Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Seroprotection rate (SPR) was defined as the number of subjects with H1N1 reciprocal HI titers ≥ 1:40 against the tested vaccine virus.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Seroconversion Factor for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Geometric mean fold-rise (GMFR), or seronversion factor (SCF), was defined as the geometric mean of the within-subject ratios of the post-vaccination reciprocal HI titer to the pre-vaccination reciprocal HI titer for the vaccine virus.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 122 to Day 164)."},{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."},{"measure":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164)."}],"secondaryOutcomes":[{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","timeFrame":"At Day 122 and Day 304"},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","timeFrame":"At Days 122 and 304"},{"measure":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","timeFrame":"Entire study period up to Day 507"},{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","timeFrame":"At Days 0 and 304"},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","timeFrame":"At Day 0 and Day 304"},{"measure":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","timeFrame":"For the entire study period up to Day 507"},{"measure":"Cell-mediated Immunogenicity (CMI) in Terms of T-cell Markers Related to A/California/7/2009, A/Brisbane/59/2007, B/Brisbane/59/2007 and A/Uruguay/716/2007 Antigens","description":"CD4 T cell-mediated immune responses against the antigens A/California/7/2009, A/Brisbane/59/2007 and A/Uruguay/716/2007 were analyzed for cells expressing at least 2 of the following immune markers: CD40 Ligand, Interleukin-2, Tumor Necrosis Factor alpha or Interferon-gamma.\n\nThe frequency was presented as number of cytokine-producing CD4+ cells per million CD4+ cells. All doubles= T cell expressing at least 2 cytokines.\n\nSubjects with missing results were not included.","timeFrame":"Before administration of Arepanrix vaccine (Day 0 to Day 122)"},{"measure":"Cell-mediated Immunogenicity (CMI) in Terms of Tcell Markers Related to A/California/7/2009, A/Brisbane/59/2007, B/Brisbane/59/2007 and A/Uruguay/716/2007 Antigens","description":"CD4 T cell-mediated immune responses against the antigens A/California/7/2009, A/Brisbane/59/2007 and A/Uruguay/716/2007 were analyzed for cells expressing at least 2 of the following immune markers: CD40 Ligand, Interleukin2, Tumor Necrosis Factor alpha or Interferongamma. The frequency was presented as number of cytokineproducing CD4+ cells per million CD4+ cells. All doubles= T cell expressing at least 2 cytokines.","timeFrame":"After the administration of Arepanrix vaccine (Day 125 to 304)"},{"measure":"Number of Subjects Reporting Any and Related Potential Immune-mediated Disease (pIMDs).","description":"pIMDs are a subset of adverse events (AEs) that include both clearly autoimmune diseases and also other inflammatory and/or neurologic disorders which may or may not have an autoimmune etiology. Related = symptom assed by the investigator as causally related to the study vaccination.","timeFrame":"During the entire study period (up to Day 507)."},{"measure":"Number of Subjects Reporting Any and Related Medically Attended Adverse Events (MAEs).","description":"MAEs refer to events that required medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (medical doctor) for any reason. Related = symptom assed by the investigator as causally related to the study vaccination.","timeFrame":"During the entire study period (up to Day 507)."},{"measure":"Number of Subjects Reporting Unsolicited AEs.","description":"An unsolicited adverse event is any adverse event (i.e. any untoward medical occurrence in a patient or clinical investigation subject, temporally associated with use of a medicinal product, whether or not considered related to the medicinal product) reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms.\n\nUnsolicited AEs were collected after the administration of the Flulaval vaccine or the placebo dose and the data has been pooled based on the vaccination received at Day 0.","timeFrame":"Up to 21-day (Days 0-20) after vaccination"},{"measure":"Number of Subjects Reporting Unsolicited AEs.","description":"Unsolicited AEs were collected after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.\n\nAn unsolicited adverse event is any adverse event (i.e. any untoward medical occurrence in a patient or clinical investigation subject, temporally associated with use of a medicinal product, whether or not considered related to the medicinal product) reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms.","timeFrame":"Within 84 days following first dose or 63 days following second dose of vaccine."},{"measure":"Number of Subjects Reporting Any and Related Serious Adverse Events (SAEs).","description":"SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects. Related = symptom assed by the investigator as causally related to the study vaccination.","timeFrame":"During the entire study period (up to Day 507)."},{"measure":"Number of Subjects Reporting Any and Related Serious Adverse Events (SAEs).","description":"SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects. Related = symptom assed by the investigator as causally related to the study vaccination. Missing values will be added once they become available.","timeFrame":"Up to Day 234"},{"measure":"Number of Subjects Reporting Any and Related Medically Attended Adverse Events (MAEs).","description":"MAEs refer to events that required medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (medical doctor) for any reason. Related = symptom assed by the investigator as causally related to the study vaccination.","timeFrame":"Within Days 0-233"},{"measure":"Number of Subjects Reporting Any and Related Potential Immune-mediated Disease (pIMDs).","description":"pIMDs are a subset of adverse events (AEs) that include both clearly autoimmune diseases and also other inflammatory and/or neurologic disorders which may or may not have an autoimmune etiology. Related = symptom assed by the investigator as causally related to the study vaccination.","timeFrame":"Within Days 0-233"},{"measure":"Number of Subjects Reporting Solicited Local Symptoms From Flulaval Group and Placebo Group.","description":"Solicited local symptoms assessed were pain, redness and swelling and data collected was pooled by administration of vaccination received at Day 0 (i.e. Flulaval or Saline placebo).\n\nAny was defined as any solicited local symptom reported irrespective of intensity. Grade 3 pain was defined as pain that prevented normal activity. Grade 3 redness and swelling were defined as redness/swelling above 100 millimeter (mm).","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination."},{"measure":"Number of Subjects Reporting Solicited General Symptoms From Flulaval Group and Placebo Group.","description":"Solicited general symptoms assessed were fatigue, headache, joint pain at other location, muscle aches, shivering, sweating and temperature (= axillary temperature equal to or above 38.0 degrees Celsius (°C)) and data collected was pooled by administration of vaccination received at Day 0 (i.e. Flulaval or Saline placebo).\n\nAny = any solicited general symptom reported irrespective of intensity and relationship to vaccination. Related = symptoms considered by the investigator to have a causal relationship to vaccination. Grade 3 symptoms = symptoms that prevented normal activity. Grade 3 fever = axillary temperature above 39.0°C.","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination."},{"measure":"Number of Subjects Reporting Solicited Local Symptoms From Flulaval/Arepanrix Group,Flulaval/Unadjuvanted Arepanrix Group,Placebo/Arepanrix Group and Placebo/Unadjuvanted Arepanrix Group","description":"Solicited local symptoms assessed were pain, redness and swelling and were collected after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.\n\nAny was defined as any solicited local symptom reported irrespective of intensity. Grade 3 pain was defined as pain that prevented normal activity. Grade 3 redness and swelling were defined as redness/swelling above 100 millimeter (mm).","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination."},{"measure":"Number of Subjects Reporting Solicited General Symptoms From Flulaval/Arepanrix Group,Flulaval/Unadjuvanted Arepanrix Group, Placebo/Arepanrix Group and Placebo/Unadjuvanted Arepanrix Group.","description":"Solicited general symptoms assessed were fatigue, headache, joint pain at other location, muscle aches, shivering, sweating and temperature (= axillary temperature equal to or above 38.0 degrees Celsius (°C)) and were collected after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.\n\nAny = any solicited general symptom reported irrespective of intensity and relationship to vaccination. Related = symptoms considered by the investigator to have a causal relationship to vaccination. Grade 3 symptoms = symptoms that prevented normal activity. Grade 3 fever = axillary temperature above 39.0°C.","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination."},{"measure":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Haematological Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were white blood cells (WBC), neutrophils (NEU), lymphocytes (LYM), monocytes (MON), eosinophils (EOS), basophils (BAS), red blood cells (RBC), hemoglobin (Hgb), hematocrit (Hct) and platelets (PLA). For each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","timeFrame":"On Days 0, 21, 122 and 164"},{"measure":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Biochemistry Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), alkaline phosphatise (AP), creatinine (CREA), blood urea nitrogen (BUN) and bilirubin (BIL) (total (T) and direct (D)).\n\nFor each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","timeFrame":"On Days 0, 21, 122 and 164"},{"measure":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Haematological Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were white blood cells (WBC), neutrophils (NEU), lymphocytes (LYM), monocytes (MON), eosinophils (EOS), basophils (BAS), red blood cells (RBC), hemoglobin (Hgb), hematocrit (Hct) and platelets (PLA). For each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","timeFrame":"At Day 304"},{"measure":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Biochemistry Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), alkaline phosphatase (AP), creatinine (CREA), blood urea nitrogen (BUN), and bilirubin (BIL) (total (T) and direct (D)). For each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","timeFrame":"At Day 304"},{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.\n\nSeropositivity rates of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14 and 21 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122"},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs). GMTs of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14, 21 and 122 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122"},{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164."},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164."},{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.\n\nSeropositivity rates of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14, 21 and 122 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122"},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs). GMTs of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14, 21 and 122 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122"},{"measure":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164."},{"measure":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who the investigator believes can and will comply with the requirements of the protocol (e.g., completion of the diary cards, return for follow-up visits).\n* Written informed consent obtained from the subject.\n* Male or female adults, 19-40 years of age at the time of the first vaccination.\n* Body weight of at least 110 pounds (49.9 kg).\n* Safety laboratory tests results within the parameters specified by protocol.\n* Satisfactory baseline medical assessment by physical examination (stable health status with no exclusionary conditions). Stable health status is defined as the absence of a health event satisfying the definition of a serious adverse event, or a change in an ongoing drug therapy due to therapeutic failure or symptoms of drug toxicity, within one month prior to enrollment.\n* Comprehension of the study requirements, ability to comprehend and comply with procedures for collection of safety data, expressed availability for the required study period, and ability and willingness to attend scheduled visits as documented by signature on the informed consent document.\n* Access to a consistent means of telephone contact, which may be either in the home or at the workplace, land line, or mobile, but NOT a pay phone or other multiple-user device (i.e., a common-use phone serving multiple rooms or apartments).\n* Female subjects of non-childbearing potential may be enrolled in the study.\n* Non-childbearing potential is defined as current tubal ligation, hysterectomy, ovariectomy, or post-menopause.\n* Female subjects of childbearing potential may be enrolled in the study, if the subject:\n* has practiced adequate contraception for 30 days prior to vaccination, and\n* has a negative pregnancy test on the day of vaccination, and\n* has agreed to continue adequate contraception during the entire treatment period and for 2 months after completion of the vaccination series\n\nExclusion Criteria:\n\n* Previous vaccination with an A/California/7/2009 (H1N1)v-like virus vaccine\n* A medical history of physician-confirmed infection with an A/California/7/2009 (H1N1)v-like virus.\n* Prior receipt at any time of any seasonal influenza vaccine.\n* Planned administration of any vaccine not foreseen by the study protocol (including any influenza vaccine other than the study vaccine) between Days 0 and the Day 164 phlebotomy.\n* Administration of any licensed vaccine within 30 days before the first study vaccine dose.\n* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccines within 30 days preceding the first dose of study vaccine, or planned use during the study period.\n* Receipt of systemic glucocorticoids (e.g., prednisone ≥ 0.5 mg/kg/day, or ≥ 10 mg/day \\[whichever is less\\] for more than 14 consecutive days) within one month prior to study enrolment, or any other cytotoxic or immunosuppressive drug within six months of study enrolment. Topical, intra-articularly injected, or inhaled glucocorticoids, topical calcineurin inhibitors or imiquimod are allowed.\n* Receipt of any immunoglobulins and/or any blood products within 9 months of study enrolment or planned administration of any of these products during the study period.\n* Presence of evidence of substance abuse or of neurological or psychiatric diagnoses which, even if stable, are deemed by the investigator to render the potential subject unable/unlikely to provide accurate safety reports.\n* History of anemia.\n* Presence of a temperature ≥ 38.0ºC (≥100.4ºF), (oral temperature assessment preferred), or acute symptoms greater than \"mild\" severity on the scheduled date of first vaccination\n* Diagnosed with cancer, or treatment for cancer, within 3 years.\n* Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination. (No laboratory testing is required.)\n* Any significant disorder of coagulation or treatment with warfarin derivatives or heparin. Persons receiving individual doses of low molecular weight heparin outside of 24 hours prior to vaccination are eligible. Persons receiving prophylactic antiplatelet medications, e.g., low-dose acetylsalicylic acid, and without a clinically-apparent bleeding tendency, are eligible.\n* An acute evolving neurological disorder or history of Guillain-Barré syndrome within six weeks of receipt of any vaccine.\n* Any known or suspected allergy to any constituent of influenza vaccines (including egg proteins or mercurial preservatives); a history of anaphylactic-type reaction to consumption of eggs; or a history of severe adverse reaction to any vaccine.\n* Known pregnancy or a positive urine beta-human chorionic gonadotropin (β-HCG) test result prior to first vaccination.\n* Lactating or nursing women.","healthyVolunteers":true,"sex":"ALL","minimumAge":"19 Years","maximumAge":"40 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"GSK Clinical Trials","affiliation":"GlaxoSmithKline","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"GSK Investigational Site","city":"Milford","state":"Massachusetts","zip":"01757","country":"United States","geoPoint":{"lat":42.13982,"lon":-71.51617}},{"facility":"GSK Investigational Site","city":"Salisbury","state":"North Carolina","zip":"28144","country":"United States","geoPoint":{"lat":35.67097,"lon":-80.47423}},{"facility":"GSK Investigational Site","city":"Winston-Salem","state":"North Carolina","zip":"27103","country":"United States","geoPoint":{"lat":36.09986,"lon":-80.24422}}]},"referencesModule":{"seeAlsoLinks":[{"label":"Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.","url":"https://www.clinicalstudydatarequest.com"}],"availIpds":[{"id":"113483","type":"Individual Participant Data Set","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"113483","type":"Dataset Specification","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"113483","type":"Informed Consent Form","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"113483","type":"Clinical Study Report","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"113483","type":"Statistical Analysis Plan","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"113483","type":"Study Protocol","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site."}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"FG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"FG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"FG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"33"},{"groupId":"FG001","numSubjects":"34"},{"groupId":"FG002","numSubjects":"33"},{"groupId":"FG003","numSubjects":"33"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"26"},{"groupId":"FG001","numSubjects":"33"},{"groupId":"FG002","numSubjects":"25"},{"groupId":"FG003","numSubjects":"27"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"8"},{"groupId":"FG003","numSubjects":"6"}]}],"dropWithdraws":[{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"8"},{"groupId":"FG003","numSubjects":"6"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"BG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"BG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"BG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"BG004","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"33"},{"groupId":"BG003","value":"33"},{"groupId":"BG004","value":"133"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29.6","spread":"6.44"},{"groupId":"BG001","value":"29.0","spread":"7.05"},{"groupId":"BG002","value":"28.6","spread":"6.17"},{"groupId":"BG003","value":"29.8","spread":"7.24"},{"groupId":"BG004","value":"29.3","spread":"6.73"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"17"},{"groupId":"BG003","value":"21"},{"groupId":"BG004","value":"72"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"16"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"61"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Seroconverted Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Seroconversion rate (SCR) was defined as the number of subjects who have either a pre-vaccination reciprocal HI titer \\< 10 and a post-vaccination reciprocal titer ≥ 40, or a pre-vaccination reciprocal HI titer ≥ 10 and at least a 4-fold increase in post vaccination reciprocal titer against the vaccine virus.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]}]}]},{"type":"PRIMARY","title":"Number of Seroprotected Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Seroprotection rate (SPR) was defined as the number of subjects with H1N1 reciprocal HI titers ≥ 40 against the tested vaccine virus.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}]}]},{"type":"PRIMARY","title":"Seroconversion Factor for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Geometric mean fold-rise (GMFR), or seronversion factor (SCF), was defined as the geometric mean of the within-subject ratios of the post-vaccination reciprocal HI titer to the pre-vaccination reciprocal HI titer for the vaccine virus.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Fold","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 122 to Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40.3","lowerLimit":"22.9","upperLimit":"71.2"},{"groupId":"OG001","value":"20.8","lowerLimit":"12.5","upperLimit":"34.6"},{"groupId":"OG002","value":"57.4","lowerLimit":"31.6","upperLimit":"104.2"},{"groupId":"OG003","value":"25.8","lowerLimit":"15.9","upperLimit":"41.8"}]}]}]},{"type":"PRIMARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}]}]},{"type":"PRIMARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"650.7","lowerLimit":"485.5","upperLimit":"872.1"},{"groupId":"OG001","value":"259.4","lowerLimit":"186.4","upperLimit":"361.0"},{"groupId":"OG002","value":"799.0","lowerLimit":"630.5","upperLimit":"1012.4"},{"groupId":"OG003","value":"332.7","lowerLimit":"222.0","upperLimit":"498.6"}]}]}]},{"type":"PRIMARY","title":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"20"}]}]}]},{"type":"PRIMARY","title":"Number of Seroconverted Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Seroconversion rate (SCR) was defined as the number of subjects who have either a pre-vaccination reciprocal HI titer \\< 1:10 and a post-vaccination reciprocal titer ≥ 1:40, or a pre-vaccination reciprocal HI titer ≥ 10 and at least a 4-fold increase in post vaccination reciprocal titer against the vaccine virus.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"}]}]}]},{"type":"PRIMARY","title":"Number of Seroprotected Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Seroprotection rate (SPR) was defined as the number of subjects with H1N1 reciprocal HI titers ≥ 1:40 against the tested vaccine virus.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"14"}]}]}]},{"type":"PRIMARY","title":"Seroconversion Factor for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Geometric mean fold-rise (GMFR), or seronversion factor (SCF), was defined as the geometric mean of the within-subject ratios of the post-vaccination reciprocal HI titer to the pre-vaccination reciprocal HI titer for the vaccine virus.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Fold increase","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 122 to Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.5","lowerLimit":"4.8","upperLimit":"11.8"},{"groupId":"OG001","value":"4.7","lowerLimit":"3.2","upperLimit":"7.0"},{"groupId":"OG002","value":"2.6","lowerLimit":"2.0","upperLimit":"3.3"},{"groupId":"OG003","value":"1.9","lowerLimit":"1.5","upperLimit":"2.6"}]}]}]},{"type":"PRIMARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"27"}]}]}]},{"type":"PRIMARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"144.9","lowerLimit":"97.2","upperLimit":"216.1"},{"groupId":"OG001","value":"123.1","lowerLimit":"87.1","upperLimit":"174.0"},{"groupId":"OG002","value":"49.2","lowerLimit":"33.9","upperLimit":"71.2"},{"groupId":"OG003","value":"35.2","lowerLimit":"25.7","upperLimit":"48.2"}]}]}]},{"type":"PRIMARY","title":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"21 days following the second dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccines (At Day 164).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"3"}]}]}]},{"type":"SECONDARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 304 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen for blood sample taken at Day 304.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"At Day 122 and Day 304","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":">=1:10 Flu A/CAL/7/09 H1N1 Day 122 (N=21;32;21;27)","categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"13"}]}]},{"title":">=1:10 Flu A/CAL/7/09 H1N1 Day 304 (N=21;32;21;27)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}]}]},{"type":"SECONDARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 304 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen for blood sample taken at Day 304.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"At Days 122 and 304","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"GMT Flu A/CAL/7/09 H1N1 Day 122","categories":[{"measurements":[{"groupId":"OG000","value":"16.1","lowerLimit":"8.9","upperLimit":"29.3"},{"groupId":"OG001","value":"12.8","lowerLimit":"7.8","upperLimit":"21.0"},{"groupId":"OG002","value":"15.6","lowerLimit":"8.2","upperLimit":"29.5"},{"groupId":"OG003","value":"12.9","lowerLimit":"8.1","upperLimit":"20.7"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 304","categories":[{"measurements":[{"groupId":"OG000","value":"157.4","lowerLimit":"98.2","upperLimit":"252.2"},{"groupId":"OG001","value":"100.3","lowerLimit":"68.0","upperLimit":"148.2"},{"groupId":"OG002","value":"289.9","lowerLimit":"188.2","upperLimit":"446.6"},{"groupId":"OG003","value":"116.0","lowerLimit":"72.7","upperLimit":"185.2"}]}]}]},{"type":"SECONDARY","title":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 304 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at Day 304.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Entire study period up to Day 507","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"17"}]}]}]},{"type":"SECONDARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 304 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen for blood sample taken at Day 304.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"At Days 0 and 304","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":">=1:10 Flu A/BRI/59/07 H1N1 Day 0 (N=21;32;21;27)","categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"20"},{"groupId":"OG003","value":"22"}]}]},{"title":">=1:10 Flu A/BRI/59/07 H1N1 Day 304 (N=21;32;21;27","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}]}]},{"type":"SECONDARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 304 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen for blood sample taken at Day 304.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"At Day 0 and Day 304","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"GMT Flu A/BRI/59/07 H1N1 Day 0","categories":[{"measurements":[{"groupId":"OG000","value":"19.3","lowerLimit":"13.2","upperLimit":"28.2"},{"groupId":"OG001","value":"25.6","lowerLimit":"17.2","upperLimit":"37.9"},{"groupId":"OG002","value":"21.6","lowerLimit":"15.4","upperLimit":"30.4"},{"groupId":"OG003","value":"18.2","lowerLimit":"12.4","upperLimit":"26.7"}]}]},{"title":"GMT Flu A/BRI/59/07 H1N1 Day 304","categories":[{"measurements":[{"groupId":"OG000","value":"129.0","lowerLimit":"89.8","upperLimit":"185.2"},{"groupId":"OG001","value":"114.4","lowerLimit":"80.0","upperLimit":"163.4"},{"groupId":"OG002","value":"48.0","lowerLimit":"35.5","upperLimit":"64.9"},{"groupId":"OG003","value":"37.0","lowerLimit":"25.5","upperLimit":"53.7"}]}]}]},{"type":"SECONDARY","title":"Vaccine Response Rate (VRR) for Microneutralization (MN) Antibodies Titers Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"VRR for microneutralization titers was defined as the incidence rate of vaccinees with at least a 4-fold increase in post vaccination reciprocal titer relative to Day 0. The cut-off value for microneutralization titers is 1:28.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 304 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at Day 304.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"For the entire study period up to Day 507","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"7"}]}]}]},{"type":"SECONDARY","title":"Cell-mediated Immunogenicity (CMI) in Terms of T-cell Markers Related to A/California/7/2009, A/Brisbane/59/2007, B/Brisbane/59/2007 and A/Uruguay/716/2007 Antigens","description":"CD4 T cell-mediated immune responses against the antigens A/California/7/2009, A/Brisbane/59/2007 and A/Uruguay/716/2007 were analyzed for cells expressing at least 2 of the following immune markers: CD40 Ligand, Interleukin-2, Tumor Necrosis Factor alpha or Interferon-gamma.\n\nThe frequency was presented as number of cytokine-producing CD4+ cells per million CD4+ cells. All doubles= T cell expressing at least 2 cytokines.\n\nSubjects with missing results were not included.","populationDescription":"The ATP cohort for immunogenicity at Day 164 included subjects who received protocol specified vaccine(s) during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after second H1N1 vaccine dose (Day 164). Subjects with missing results were not included.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"cells/million T cells","timeFrame":"Before administration of Arepanrix vaccine (Day 0 to Day 122)","groups":[{"id":"OG000","title":"Flulaval Group","description":"Subjects received Flulaval vaccine on Day 0 and either adjuvanted or unadjuvanted formulation of Arepanrix on Days 122 and 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Placebo Group","description":"Subjects received a saline placebo on Day 0 and either adjuvanted or unadjuvanted formulation of Arepanrix on Days 122 and 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"43"}]}],"classes":[{"title":"A/Brisbane, CD4 All doubles, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1699.0","lowerLimit":"1366.0","upperLimit":"2352.0"},{"groupId":"OG001","value":"1622.0","lowerLimit":"1070.0","upperLimit":"2492.0"}]}]},{"title":"A/Brisbane, CD4 All doubles, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"2559.0","lowerLimit":"1446.0","upperLimit":"3449.0"},{"groupId":"OG001","value":"1649.0","lowerLimit":"1260.0","upperLimit":"2440.0"}]}]},{"title":"A/Brisbane, CD4 All doubles, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2648.5","lowerLimit":"1994.0","upperLimit":"3252.5"},{"groupId":"OG001","value":"1553.0","lowerLimit":"953.0","upperLimit":"2024.0"}]}]},{"title":"A/Brisbane, CD4 All doubles, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2496.0","lowerLimit":"1754.0","upperLimit":"3662.0"},{"groupId":"OG001","value":"1599.0","lowerLimit":"1144.0","upperLimit":"2366.0"}]}]},{"title":"A/Brisbane, CD4 All doubles, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1777.0","lowerLimit":"1277.0","upperLimit":"2652.0"},{"groupId":"OG001","value":"1600.0","lowerLimit":"1031.0","upperLimit":"2253.0"}]}]},{"title":"A/California, CD4 All doubles, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1331.0","lowerLimit":"939.0","upperLimit":"2082.0"},{"groupId":"OG001","value":"1073.0","lowerLimit":"795.0","upperLimit":"1631.0"}]}]},{"title":"A/California, CD4 All doubles, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1746.0","lowerLimit":"1041.0","upperLimit":"2590.0"},{"groupId":"OG001","value":"1209.0","lowerLimit":"792.0","upperLimit":"1723.0"}]}]},{"title":"A/California, CD4 All doubles, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1917.5","lowerLimit":"1385.5","upperLimit":"2673.0"},{"groupId":"OG001","value":"1133.0","lowerLimit":"653.0","upperLimit":"1515.0"}]}]},{"title":"A/California, CD4 All doubles, Day 21 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1693.0","lowerLimit":"1243.0","upperLimit":"2325.0"},{"groupId":"OG001","value":"1267.0","lowerLimit":"742.0","upperLimit":"1785.0"}]}]},{"title":"A/California, CD4 All doubles, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1534.0","lowerLimit":"973.0","upperLimit":"2217.0"},{"groupId":"OG001","value":"970.0","lowerLimit":"620.0","upperLimit":"1530.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1318.0","lowerLimit":"851.0","upperLimit":"1903.0"},{"groupId":"OG001","value":"1131.0","lowerLimit":"732.0","upperLimit":"1723.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1751.0","lowerLimit":"1091.0","upperLimit":"2659.0"},{"groupId":"OG001","value":"1292.0","lowerLimit":"694.0","upperLimit":"1692.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 14 [N=44,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1807.0","lowerLimit":"1320.5","upperLimit":"2845.0"},{"groupId":"OG001","value":"1093.5","lowerLimit":"673.0","upperLimit":"1913.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1699.0","lowerLimit":"1187.0","upperLimit":"2590.0"},{"groupId":"OG001","value":"1245.0","lowerLimit":"746.0","upperLimit":"1734.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 122 [N=40,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1583.0","lowerLimit":"949.5","upperLimit":"2183.0"},{"groupId":"OG001","value":"1196.5","lowerLimit":"575.0","upperLimit":"1540.0"}]}]},{"title":"B/Brisbane, CD4 All doubles, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1339.0","lowerLimit":"936.0","upperLimit":"2297.0"},{"groupId":"OG001","value":"1317.0","lowerLimit":"935.0","upperLimit":"2251.0"}]}]},{"title":"B/Brisbane, CD4 All doubles, Day 7 [N=42,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1884.5","lowerLimit":"1465.0","upperLimit":"3254.0"},{"groupId":"OG001","value":"1764.5","lowerLimit":"928.5","upperLimit":"2370.5"}]}]},{"title":"B/Brisbane, CD4 All doubles, Day 14 [N=43,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2264.0","lowerLimit":"1656.0","upperLimit":"3562.0"},{"groupId":"OG001","value":"1567.0","lowerLimit":"849.0","upperLimit":"2394.0"}]}]},{"title":"B/Brisbane, CD4 All doubles, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2212.0","lowerLimit":"1633.0","upperLimit":"3137.0"},{"groupId":"OG001","value":"1520.0","lowerLimit":"1020.0","upperLimit":"2465.0"}]}]},{"title":"B/Brisbane, CD4 All doubles, Day 122 [N=41,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1688.0","lowerLimit":"1106.0","upperLimit":"2205.0"},{"groupId":"OG001","value":"1150.0","lowerLimit":"798.0","upperLimit":"1998.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1549.0","lowerLimit":"1258.0","upperLimit":"2252.0"},{"groupId":"OG001","value":"1394.0","lowerLimit":"1011.0","upperLimit":"2033.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"2443.0","lowerLimit":"1360.0","upperLimit":"3244.0"},{"groupId":"OG001","value":"1457.0","lowerLimit":"1126.0","upperLimit":"2255.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2323.5","lowerLimit":"1714.0","upperLimit":"3056.5"},{"groupId":"OG001","value":"1369.0","lowerLimit":"867.0","upperLimit":"1787.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2187.0","lowerLimit":"1480.0","upperLimit":"3291.0"},{"groupId":"OG001","value":"1453.0","lowerLimit":"1023.0","upperLimit":"2112.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1735.0","lowerLimit":"1178.0","upperLimit":"2540.0"},{"groupId":"OG001","value":"1404.0","lowerLimit":"944.0","upperLimit":"2022.0"}]}]},{"title":"A/California, CD4 Double CD40L, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1070.0","lowerLimit":"824.0","upperLimit":"1784.0"},{"groupId":"OG001","value":"942.0","lowerLimit":"717.0","upperLimit":"1209.0"}]}]},{"title":"A/California, CD4 Double CD40L, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1337.0","lowerLimit":"885.0","upperLimit":"2291.0"},{"groupId":"OG001","value":"1077.0","lowerLimit":"708.0","upperLimit":"1321.0"}]}]},{"title":"A/California, CD4 Double CD40L, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1734.5","lowerLimit":"1097.5","upperLimit":"2452.5"},{"groupId":"OG001","value":"936.0","lowerLimit":"520.0","upperLimit":"1303.0"}]}]},{"title":"A/California, CD4 Double CD40L, Day 21 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1336.0","lowerLimit":"1073.0","upperLimit":"2220.0"},{"groupId":"OG001","value":"1010.0","lowerLimit":"542.0","upperLimit":"1527.0"}]}]},{"title":"A/California, CD4 Double CD40L, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1355.0","lowerLimit":"816.0","upperLimit":"1932.0"},{"groupId":"OG001","value":"846.0","lowerLimit":"426.0","upperLimit":"1389.0"}]}]},{"title":"A/Uruguay, CD4 Double CD40L, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1134.0","lowerLimit":"824.0","upperLimit":"1749.0"},{"groupId":"OG001","value":"1076.0","lowerLimit":"635.0","upperLimit":"1444.0"}]}]},{"title":"A/Uruguay, CD4 Double CD40L, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1521.0","lowerLimit":"1009.0","upperLimit":"2191.0"},{"groupId":"OG001","value":"1076.0","lowerLimit":"595.0","upperLimit":"1571.0"}]}]},{"title":"A/Uruguay, CD4 Double CD40L, Day 14 [N=44,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1585.5","lowerLimit":"1157.0","upperLimit":"2553.0"},{"groupId":"OG001","value":"809.0","lowerLimit":"656.0","upperLimit":"1692.0"}]}]},{"title":"A/Uruguay, CD4 Double CD40L, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1504.0","lowerLimit":"1071.0","upperLimit":"2144.0"},{"groupId":"OG001","value":"1060.0","lowerLimit":"655.0","upperLimit":"1569.0"}]}]},{"title":"A/Uruguay, CD4 Double CD40L, Day 122 [N=40,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1402.0","lowerLimit":"844.0","upperLimit":"1796.0"},{"groupId":"OG001","value":"1033.5","lowerLimit":"540.0","upperLimit":"1358.0"}]}]},{"title":"B/Brisbane, CD4 Double CD40L, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1283.0","lowerLimit":"813.0","upperLimit":"2123.0"},{"groupId":"OG001","value":"1135.0","lowerLimit":"883.0","upperLimit":"1915.0"}]}]},{"title":"B/Brisbane, CD4 Double CD40L, Day 7 [N=42,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1598.5","lowerLimit":"1312.0","upperLimit":"3071.0"},{"groupId":"OG001","value":"1436.5","lowerLimit":"857.0","upperLimit":"2035.0"}]}]},{"title":"B/Brisbane, CD4 Double CD40L, Day 14 [N=43,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1952.0","lowerLimit":"1260.0","upperLimit":"3155.0"},{"groupId":"OG001","value":"1356.0","lowerLimit":"753.0","upperLimit":"2138.0"}]}]},{"title":"B/Brisbane, CD4 Double CD40L, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1955.0","lowerLimit":"1304.0","upperLimit":"2614.0"},{"groupId":"OG001","value":"1296.0","lowerLimit":"927.0","upperLimit":"1925.0"}]}]},{"title":"B/Brisbane, CD4 Double CD40L, Day 122 [N=41,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1494.0","lowerLimit":"1066.0","upperLimit":"2092.0"},{"groupId":"OG001","value":"1051.0","lowerLimit":"717.0","upperLimit":"1766.0"}]}]},{"title":"A/Brisbane, CD4 Double IFNg, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1441.0","lowerLimit":"1040.0","upperLimit":"1900.0"},{"groupId":"OG001","value":"1161.0","lowerLimit":"745.0","upperLimit":"1868.0"}]}]},{"title":"A/Brisbane, CD4 Double IFNg, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1964.0","lowerLimit":"1236.0","upperLimit":"3008.0"},{"groupId":"OG001","value":"1231.0","lowerLimit":"1033.0","upperLimit":"2016.0"}]}]},{"title":"A/Brisbane, CD4 Double IFNg, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2148.0","lowerLimit":"1591.0","upperLimit":"2778.0"},{"groupId":"OG001","value":"1196.0","lowerLimit":"776.0","upperLimit":"1729.0"}]}]},{"title":"A/Brisbane, CD4 Double IFNg, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1973.0","lowerLimit":"1283.0","upperLimit":"2858.0"},{"groupId":"OG001","value":"1121.0","lowerLimit":"903.0","upperLimit":"1903.0"}]}]},{"title":"A/Brisbane, CD4 Double IFNg, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1535.0","lowerLimit":"1146.0","upperLimit":"2205.0"},{"groupId":"OG001","value":"1181.0","lowerLimit":"742.0","upperLimit":"1883.0"}]}]},{"title":"A/California, CD4 Double IFNg, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"913.0","lowerLimit":"646.0","upperLimit":"1444.0"},{"groupId":"OG001","value":"823.0","lowerLimit":"577.0","upperLimit":"1222.0"}]}]},{"title":"A/California, CD4 Double IFNg, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1307.0","lowerLimit":"912.0","upperLimit":"2073.0"},{"groupId":"OG001","value":"1000.0","lowerLimit":"604.0","upperLimit":"1306.0"}]}]},{"title":"A/California, CD4 Double IFNg, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1453.0","lowerLimit":"1139.5","upperLimit":"1992.0"},{"groupId":"OG001","value":"808.0","lowerLimit":"368.0","upperLimit":"1260.0"}]}]},{"title":"A/California, CD4 Double IFNg, Day 21 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1398.0","lowerLimit":"1035.0","upperLimit":"1773.0"},{"groupId":"OG001","value":"943.5","lowerLimit":"499.0","upperLimit":"1402.0"}]}]},{"title":"A/California, CD4 Double IFNg, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1019.0","lowerLimit":"703.0","upperLimit":"1579.0"},{"groupId":"OG001","value":"910.0","lowerLimit":"422.0","upperLimit":"1193.0"}]}]},{"title":"A/Uruguay, CD4 Double IFNg, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1073.0","lowerLimit":"725.0","upperLimit":"1538.0"},{"groupId":"OG001","value":"962.0","lowerLimit":"552.0","upperLimit":"1478.0"}]}]},{"title":"A/Uruguay, CD4 Double IFNg, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1460.0","lowerLimit":"1019.0","upperLimit":"2011.0"},{"groupId":"OG001","value":"1027.0","lowerLimit":"663.0","upperLimit":"1323.0"}]}]},{"title":"A/Uruguay, CD4 Double IFNg, Day 14 [N=44,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1463.0","lowerLimit":"1077.0","upperLimit":"2289.5"},{"groupId":"OG001","value":"842.0","lowerLimit":"538.0","upperLimit":"1539.0"}]}]},{"title":"A/Uruguay, CD4 Double IFNg, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1361.0","lowerLimit":"941.0","upperLimit":"2070.0"},{"groupId":"OG001","value":"1005.0","lowerLimit":"557.0","upperLimit":"1528.0"}]}]},{"title":"A/Uruguay, CD4 Double IFNg, Day 122 [N=40,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1230.0","lowerLimit":"734.0","upperLimit":"1571.5"},{"groupId":"OG001","value":"1009.0","lowerLimit":"464.0","upperLimit":"1290.0"}]}]},{"title":"B/Brisbane, CD4 Double IFNg, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1158.0","lowerLimit":"886.0","upperLimit":"2090.0"},{"groupId":"OG001","value":"1124.0","lowerLimit":"740.0","upperLimit":"1970.0"}]}]},{"title":"B/Brisbane, CD4 Double IFNg, Day 7 [N=42,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1532.5","lowerLimit":"1288.0","upperLimit":"2787.0"},{"groupId":"OG001","value":"1406.5","lowerLimit":"832.5","upperLimit":"2205.5"}]}]},{"title":"B/Brisbane, CD4 Double IFNg, Day 14 [N=43,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1790.0","lowerLimit":"1313.0","upperLimit":"2911.0"},{"groupId":"OG001","value":"1281.0","lowerLimit":"771.0","upperLimit":"2192.0"}]}]},{"title":"B/Brisbane, CD4 Double IFNg, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1752.0","lowerLimit":"1410.0","upperLimit":"2635.0"},{"groupId":"OG001","value":"1262.0","lowerLimit":"981.0","upperLimit":"2227.0"}]}]},{"title":"B/Brisbane, CD4 Double IFNg, Day 122 [N=41,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1222.0","lowerLimit":"1023.0","upperLimit":"1812.0"},{"groupId":"OG001","value":"1109.5","lowerLimit":"741.5","upperLimit":"1876.0"}]}]},{"title":"A/Brisbane, CD4 Double IL-2, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1464.0","lowerLimit":"946.0","upperLimit":"1835.0"},{"groupId":"OG001","value":"1220.0","lowerLimit":"966.0","upperLimit":"1926.0"}]}]},{"title":"A/Brisbane, CD4 Double IL-2, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"2089.0","lowerLimit":"1260.0","upperLimit":"2887.0"},{"groupId":"OG001","value":"1347.0","lowerLimit":"1068.0","upperLimit":"2058.0"}]}]},{"title":"A/Brisbane, CD4 Double IL-2, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"2255.0","lowerLimit":"1683.0","upperLimit":"2705.0"},{"groupId":"OG001","value":"1284.0","lowerLimit":"797.0","upperLimit":"1643.0"}]}]},{"title":"A/Brisbane, CD4 Double IL-2, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1991.0","lowerLimit":"1420.0","upperLimit":"2898.0"},{"groupId":"OG001","value":"1427.0","lowerLimit":"884.0","upperLimit":"2037.0"}]}]},{"title":"A/Brisbane, CD4 Double IL-2, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1585.0","lowerLimit":"1038.0","upperLimit":"2400.0"},{"groupId":"OG001","value":"1323.5","lowerLimit":"858.0","upperLimit":"1831.0"}]}]},{"title":"A/California, CD4 Double IL-2, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1103.0","lowerLimit":"740.0","upperLimit":"1810.0"},{"groupId":"OG001","value":"855.0","lowerLimit":"565.0","upperLimit":"1456.0"}]}]},{"title":"A/California, CD4 Double IL-2, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1370.0","lowerLimit":"888.0","upperLimit":"2256.0"},{"groupId":"OG001","value":"1001.0","lowerLimit":"738.0","upperLimit":"1604.0"}]}]},{"title":"A/California, CD4 Double IL-2, Day 14 [N=44,44]","categories":[{"measurements":[{"groupId":"OG000","value":"1590.0","lowerLimit":"1222.5","upperLimit":"2222.5"},{"groupId":"OG001","value":"1010.0","lowerLimit":"520.0","upperLimit":"1282.0"}]}]},{"title":"A/California, CD4 Double IL-2, Day 21 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1299.0","lowerLimit":"1011.0","upperLimit":"2036.0"},{"groupId":"OG001","value":"1061.0","lowerLimit":"659.0","upperLimit":"1504.0"}]}]},{"title":"A/California, CD4 Double IL-2, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1252.0","lowerLimit":"764.0","upperLimit":"1801.0"},{"groupId":"OG001","value":"835.0","lowerLimit":"442.0","upperLimit":"1292.0"}]}]},{"title":"A/Uruguay, CD4 Double IL-2, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1092.0","lowerLimit":"701.0","upperLimit":"1516.0"},{"groupId":"OG001","value":"939.0","lowerLimit":"645.0","upperLimit":"1439.0"}]}]},{"title":"A/Uruguay, CD4 Double IL-2, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1375.0","lowerLimit":"818.0","upperLimit":"2300.0"},{"groupId":"OG001","value":"1116.0","lowerLimit":"594.0","upperLimit":"1475.0"}]}]},{"title":"A/Uruguay, CD4 Double IL-2, Day 14 [N=44,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1598.0","lowerLimit":"1042.0","upperLimit":"2365.5"},{"groupId":"OG001","value":"975.0","lowerLimit":"585.0","upperLimit":"1584.0"}]}]},{"title":"A/Uruguay, CD4 Double IL-2, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1406.0","lowerLimit":"942.0","upperLimit":"2074.0"},{"groupId":"OG001","value":"1168.0","lowerLimit":"612.0","upperLimit":"1552.0"}]}]},{"title":"A/Uruguay, CD4 Double IL-2, Day 122 [N=40,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1276.5","lowerLimit":"759.0","upperLimit":"1920.5"},{"groupId":"OG001","value":"1049.0","lowerLimit":"525.0","upperLimit":"1280.0"}]}]},{"title":"B/Brisbane, CD4 Double IL-2, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1191.0","lowerLimit":"663.0","upperLimit":"1787.0"},{"groupId":"OG001","value":"1110.0","lowerLimit":"777.0","upperLimit":"1834.0"}]}]},{"title":"B/Brisbane, CD4 Double IL-2, Day 7 [N=42,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1677.0","lowerLimit":"1154.0","upperLimit":"2536.0"},{"groupId":"OG001","value":"1442.5","lowerLimit":"823.5","upperLimit":"1887.0"}]}]},{"title":"B/Brisbane, CD4 Double IL-2, Day 14 [N=43,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1879.0","lowerLimit":"1369.0","upperLimit":"2887.0"},{"groupId":"OG001","value":"1242.0","lowerLimit":"677.0","upperLimit":"1884.0"}]}]},{"title":"B/Brisbane, CD4 Double IL-2, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1784.0","lowerLimit":"1464.0","upperLimit":"2642.0"},{"groupId":"OG001","value":"1336.0","lowerLimit":"873.0","upperLimit":"1985.0"}]}]},{"title":"B/Brisbane, CD4 Double IL-2, Day 122 [N=41,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1378.0","lowerLimit":"896.0","upperLimit":"1887.0"},{"groupId":"OG001","value":"961.5","lowerLimit":"648.0","upperLimit":"1626.0"}]}]},{"title":"A/Brisbane, CD4 Double TNF-a, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1339.0","lowerLimit":"899.0","upperLimit":"1615.0"},{"groupId":"OG001","value":"1153.0","lowerLimit":"749.0","upperLimit":"1757.0"}]}]},{"title":"A/Brisbane, CD4 Double TNF-a, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1751.0","lowerLimit":"908.0","upperLimit":"2315.0"},{"groupId":"OG001","value":"1201.0","lowerLimit":"868.0","upperLimit":"1879.0"}]}]},{"title":"A/Brisbane, CD4 Double TNF-a, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1849.0","lowerLimit":"1164.5","upperLimit":"2332.5"},{"groupId":"OG001","value":"1032.0","lowerLimit":"554.0","upperLimit":"1747.0"}]}]},{"title":"A/Brisbane, CD4 Double TNF-a, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1474.0","lowerLimit":"1027.0","upperLimit":"2499.0"},{"groupId":"OG001","value":"1142.0","lowerLimit":"768.0","upperLimit":"1798.0"}]}]},{"title":"A/Brisbane, CD4 Double TNF-a, Day 122 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1281.0","lowerLimit":"862.0","upperLimit":"1781.0"},{"groupId":"OG001","value":"1153.0","lowerLimit":"564.0","upperLimit":"1796.0"}]}]},{"title":"A/California, CD4 Double TNF-a, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1015.0","lowerLimit":"751.0","upperLimit":"1476.0"},{"groupId":"OG001","value":"867.0","lowerLimit":"525.0","upperLimit":"1249.0"}]}]},{"title":"A/California, CD4 Double TNF-a, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1245.0","lowerLimit":"592.0","upperLimit":"1820.0"},{"groupId":"OG001","value":"976.0","lowerLimit":"576.0","upperLimit":"1279.0"}]}]},{"title":"A/California, CD4 Double TNF-a, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1338.0","lowerLimit":"913.5","upperLimit":"2042.0"},{"groupId":"OG001","value":"816.0","lowerLimit":"481.0","upperLimit":"1350.0"}]}]},{"title":"A/California, CD4 Double TNF-a, Day 21 [N=41,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1209.0","lowerLimit":"816.0","upperLimit":"1798.0"},{"groupId":"OG001","value":"936.0","lowerLimit":"503.0","upperLimit":"1318.0"}]}]},{"title":"A/California, CD4 Double TNF-a, Day 122 [N=42,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1016.0","lowerLimit":"606.0","upperLimit":"1617.0"},{"groupId":"OG001","value":"651.0","lowerLimit":"411.0","upperLimit":"1234.0"}]}]},{"title":"A/Uruguay, CD4 Double TNF-a, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"920.0","lowerLimit":"631.0","upperLimit":"1294.0"},{"groupId":"OG001","value":"786.0","lowerLimit":"561.0","upperLimit":"1317.0"}]}]},{"title":"A/Uruguay, CD4 Double TNF-a, Day 7 [N=43,41]","categories":[{"measurements":[{"groupId":"OG000","value":"1186.0","lowerLimit":"586.0","upperLimit":"1770.0"},{"groupId":"OG001","value":"986.0","lowerLimit":"570.0","upperLimit":"1338.0"}]}]},{"title":"A/Uruguay, CD4 Double TNF-a, Day 14 [N=44,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1104.0","lowerLimit":"818.0","upperLimit":"1961.0"},{"groupId":"OG001","value":"756.0","lowerLimit":"374.0","upperLimit":"1440.0"}]}]},{"title":"A/Uruguay, CD4 Double TNF-a, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1133.0","lowerLimit":"694.0","upperLimit":"1854.0"},{"groupId":"OG001","value":"909.0","lowerLimit":"498.0","upperLimit":"1378.0"}]}]},{"title":"A/Uruguay, CD4 Double TNF-a, Day 122 [N=40,42]","categories":[{"measurements":[{"groupId":"OG000","value":"1104.5","lowerLimit":"631.5","upperLimit":"1518.5"},{"groupId":"OG001","value":"849.5","lowerLimit":"493.0","upperLimit":"1218.0"}]}]},{"title":"B/Brisbane, CD4 Double TNF-a, Day 0 [N=41,41]","categories":[{"measurements":[{"groupId":"OG000","value":"986.0","lowerLimit":"606.0","upperLimit":"1426.0"},{"groupId":"OG001","value":"875.0","lowerLimit":"573.0","upperLimit":"1751.0"}]}]},{"title":"B/Brisbane, CD4 Double TNF-a, Day 7 [N=42,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1093.5","lowerLimit":"729.0","upperLimit":"1731.0"},{"groupId":"OG001","value":"1037.5","lowerLimit":"594.0","upperLimit":"1559.0"}]}]},{"title":"B/Brisbane, CD4 Double TNF-a, Day 14 [N=43,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1408.0","lowerLimit":"944.0","upperLimit":"2062.0"},{"groupId":"OG001","value":"970.0","lowerLimit":"582.0","upperLimit":"1692.0"}]}]},{"title":"B/Brisbane, CD4 Double TNF-a, Day 21 [N=41,43]","categories":[{"measurements":[{"groupId":"OG000","value":"1275.0","lowerLimit":"859.0","upperLimit":"1929.0"},{"groupId":"OG001","value":"900.0","lowerLimit":"555.0","upperLimit":"1615.0"}]}]},{"title":"B/Brisbane, CD4 Double TNF-a, Day 122 [N=41,40]","categories":[{"measurements":[{"groupId":"OG000","value":"1020.0","lowerLimit":"640.0","upperLimit":"1439.0"},{"groupId":"OG001","value":"748.0","lowerLimit":"417.5","upperLimit":"1299.0"}]}]}]},{"type":"SECONDARY","title":"Cell-mediated Immunogenicity (CMI) in Terms of Tcell Markers Related to A/California/7/2009, A/Brisbane/59/2007, B/Brisbane/59/2007 and A/Uruguay/716/2007 Antigens","description":"CD4 T cell-mediated immune responses against the antigens A/California/7/2009, A/Brisbane/59/2007 and A/Uruguay/716/2007 were analyzed for cells expressing at least 2 of the following immune markers: CD40 Ligand, Interleukin2, Tumor Necrosis Factor alpha or Interferongamma. The frequency was presented as number of cytokineproducing CD4+ cells per million CD4+ cells. All doubles= T cell expressing at least 2 cytokines.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 304 included all evaluable subjects who had not received a vaccine not specified or forbidden in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen for the blood sample taken at Day 304.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","unitOfMeasure":"cells/million T cells","timeFrame":"After the administration of Arepanrix vaccine (Day 125 to 304)","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm a t Days 0 and 122 and of the dominant arm at Day143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"A/Brisbane, CD4 All doubles,Day 125[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1582.5","lowerLimit":"1008.0","upperLimit":"2074.0"},{"groupId":"OG001","value":"1652.0","lowerLimit":"1211.0","upperLimit":"2082.0"},{"groupId":"OG002","value":"1332.0","lowerLimit":"691.5","upperLimit":"1795.5"},{"groupId":"OG003","value":"1252.0","lowerLimit":"1005.0","upperLimit":"2103.0"}]}]},{"title":"A/Brisbane, CD4 All doubles,Day 129[N=17,25,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1750.0","lowerLimit":"1453.0","upperLimit":"2641.0"},{"groupId":"OG001","value":"2099.0","lowerLimit":"1525.0","upperLimit":"2403.0"},{"groupId":"OG002","value":"1950.0","lowerLimit":"1394.0","upperLimit":"3218.0"},{"groupId":"OG003","value":"1907.0","lowerLimit":"1248.0","upperLimit":"2820.0"}]}]},{"title":"A/Brisbane, CD4 All doubles,Day 136[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"2683.0","lowerLimit":"1863.0","upperLimit":"3769.0"},{"groupId":"OG001","value":"2288.5","lowerLimit":"1945.5","upperLimit":"3136.5"},{"groupId":"OG002","value":"2546.5","lowerLimit":"1938.5","upperLimit":"4540.0"},{"groupId":"OG003","value":"2289.0","lowerLimit":"1560.0","upperLimit":"3105.0"}]}]},{"title":"A/Brisbane, CD4 All doubles,Day 143[N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2330.0","lowerLimit":"1642.0","upperLimit":"3117.0"},{"groupId":"OG001","value":"2393.0","lowerLimit":"1771.0","upperLimit":"3336.0"},{"groupId":"OG002","value":"2535.5","lowerLimit":"1886.5","upperLimit":"3980.0"},{"groupId":"OG003","value":"2310.0","lowerLimit":"1573.0","upperLimit":"2668.0"}]}]},{"title":"A/Brisbane, CD4 All doubles,Day 150[N=16,22,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2690.5","lowerLimit":"1891.0","upperLimit":"3282.0"},{"groupId":"OG001","value":"2380.0","lowerLimit":"1651.0","upperLimit":"2754.0"},{"groupId":"OG002","value":"3272.0","lowerLimit":"1882.0","upperLimit":"4328.0"},{"groupId":"OG003","value":"2200.5","lowerLimit":"1466.0","upperLimit":"2756.0"}]}]},{"title":"A/Brisbane, CD4 All doubles,Day 157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"3136.0","lowerLimit":"2389.0","upperLimit":"3827.0"},{"groupId":"OG001","value":"2178.0","lowerLimit":"1825.0","upperLimit":"2949.0"},{"groupId":"OG002","value":"2981.0","lowerLimit":"2435.0","upperLimit":"4139.0"},{"groupId":"OG003","value":"2362.5","lowerLimit":"1549.0","upperLimit":"2778.0"}]}]},{"title":"A/Brisbane, CD4 All doubles,Day 164[N=16,20,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"2906.5","lowerLimit":"1523.0","upperLimit":"3923.0"},{"groupId":"OG001","value":"2316.5","lowerLimit":"1642.5","upperLimit":"3041.0"},{"groupId":"OG002","value":"2971.0","lowerLimit":"2069.0","upperLimit":"4510.0"},{"groupId":"OG003","value":"1838.0","lowerLimit":"1293.0","upperLimit":"2769.0"}]}]},{"title":"A/Brisbane, CD4 All doubles,Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"2041.0","lowerLimit":"1658.0","upperLimit":"2727.0"},{"groupId":"OG001","value":"1945.5","lowerLimit":"1458.0","upperLimit":"2414.5"},{"groupId":"OG002","value":"2115.0","lowerLimit":"1613.0","upperLimit":"3136.0"},{"groupId":"OG003","value":"1797.0","lowerLimit":"1195.0","upperLimit":"2338.0"}]}]},{"title":"A/California,CD4 All doubles,Day 125[N=14,21,15,17","categories":[{"measurements":[{"groupId":"OG000","value":"1066.0","lowerLimit":"662.0","upperLimit":"1730.0"},{"groupId":"OG001","value":"1097.0","lowerLimit":"848.0","upperLimit":"1531.0"},{"groupId":"OG002","value":"1146.0","lowerLimit":"383.0","upperLimit":"1574.0"},{"groupId":"OG003","value":"1115.0","lowerLimit":"681.0","upperLimit":"1444.0"}]}]},{"title":"A/California,CD4 All doubles,Day 129[N=17,26,23,22","categories":[{"measurements":[{"groupId":"OG000","value":"1458.0","lowerLimit":"1148.0","upperLimit":"1859.0"},{"groupId":"OG001","value":"1576.0","lowerLimit":"1065.0","upperLimit":"1764.0"},{"groupId":"OG002","value":"1765.0","lowerLimit":"1111.0","upperLimit":"2931.0"},{"groupId":"OG003","value":"1457.0","lowerLimit":"1102.0","upperLimit":"2034.0"}]}]},{"title":"A/California,CD4 All doubles,Day 136[N=18,24,20,22","categories":[{"measurements":[{"groupId":"OG000","value":"2340.5","lowerLimit":"1527.0","upperLimit":"2820.0"},{"groupId":"OG001","value":"1779.0","lowerLimit":"1473.5","upperLimit":"2074.0"},{"groupId":"OG002","value":"2550.5","lowerLimit":"2017.0","upperLimit":"4239.5"},{"groupId":"OG003","value":"1831.5","lowerLimit":"1091.0","upperLimit":"2597.0"}]}]},{"title":"A/California,CD4 All doubles,Day 143[N=17,27,20,18","categories":[{"measurements":[{"groupId":"OG000","value":"1893.0","lowerLimit":"1281.0","upperLimit":"2411.0"},{"groupId":"OG001","value":"1735.0","lowerLimit":"1241.0","upperLimit":"2310.0"},{"groupId":"OG002","value":"2544.0","lowerLimit":"1910.0","upperLimit":"4303.5"},{"groupId":"OG003","value":"1828.0","lowerLimit":"1224.0","upperLimit":"2088.0"}]}]},{"title":"A/California,CD4 All doubles,Day 150[N=16,22,23,21","categories":[{"measurements":[{"groupId":"OG000","value":"2549.5","lowerLimit":"1732.5","upperLimit":"3570.5"},{"groupId":"OG001","value":"1918.5","lowerLimit":"1625.0","upperLimit":"2043.0"},{"groupId":"OG002","value":"3308.0","lowerLimit":"2028.0","upperLimit":"4910.0"},{"groupId":"OG003","value":"1653.0","lowerLimit":"980.0","upperLimit":"2085.0"}]}]},{"title":"A/California,CD4 All doubles,Day 157[N=17,22,20,18","categories":[{"measurements":[{"groupId":"OG000","value":"2685.0","lowerLimit":"2296.0","upperLimit":"3163.0"},{"groupId":"OG001","value":"1760.5","lowerLimit":"1287.0","upperLimit":"1987.0"},{"groupId":"OG002","value":"2971.0","lowerLimit":"2395.5","upperLimit":"4264.0"},{"groupId":"OG003","value":"1425.5","lowerLimit":"1107.0","upperLimit":"2045.0"}]}]},{"title":"A/California,CD4 All doubles,Day 164[N=16,19,19,21","categories":[{"measurements":[{"groupId":"OG000","value":"2590.0","lowerLimit":"1566.0","upperLimit":"3212.0"},{"groupId":"OG001","value":"1692.0","lowerLimit":"1322.0","upperLimit":"2404.0"},{"groupId":"OG002","value":"3168.0","lowerLimit":"2204.0","upperLimit":"5242.0"},{"groupId":"OG003","value":"1409.0","lowerLimit":"1012.0","upperLimit":"1638.0"}]}]},{"title":"A/California,CD4 All doubles,Day 304[N=18,28,19,27","categories":[{"measurements":[{"groupId":"OG000","value":"1616.0","lowerLimit":"1352.0","upperLimit":"2202.0"},{"groupId":"OG001","value":"1392.5","lowerLimit":"1250.5","upperLimit":"1982.5"},{"groupId":"OG002","value":"2138.0","lowerLimit":"1363.0","upperLimit":"2493.0"},{"groupId":"OG003","value":"1358.0","lowerLimit":"940.0","upperLimit":"1791.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 125[N=14,21,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1237.5","lowerLimit":"658.0","upperLimit":"1899.0"},{"groupId":"OG001","value":"998.0","lowerLimit":"814.0","upperLimit":"1314.0"},{"groupId":"OG002","value":"1094.5","lowerLimit":"438.0","upperLimit":"1655.5"},{"groupId":"OG003","value":"990.0","lowerLimit":"644.0","upperLimit":"1389.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 129[N=17,26,21,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1381.0","lowerLimit":"996.0","upperLimit":"1793.0"},{"groupId":"OG001","value":"1215.0","lowerLimit":"829.0","upperLimit":"1857.0"},{"groupId":"OG002","value":"1239.0","lowerLimit":"1031.0","upperLimit":"1942.0"},{"groupId":"OG003","value":"1176.5","lowerLimit":"737.0","upperLimit":"1528.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 136[N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1791.5","lowerLimit":"1119.0","upperLimit":"2198.0"},{"groupId":"OG001","value":"1576.0","lowerLimit":"1109.5","upperLimit":"1929.0"},{"groupId":"OG002","value":"1738.5","lowerLimit":"1164.5","upperLimit":"2584.0"},{"groupId":"OG003","value":"1555.0","lowerLimit":"944.0","upperLimit":"1995.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 143[N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1661.0","lowerLimit":"1067.0","upperLimit":"2078.5"},{"groupId":"OG001","value":"1566.0","lowerLimit":"989.0","upperLimit":"1863.0"},{"groupId":"OG002","value":"1999.0","lowerLimit":"1262.5","upperLimit":"2659.0"},{"groupId":"OG003","value":"1425.0","lowerLimit":"1075.0","upperLimit":"1825.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 150[N=16,21,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1921.5","lowerLimit":"1089.5","upperLimit":"2633.5"},{"groupId":"OG001","value":"1391.0","lowerLimit":"1197.0","upperLimit":"1878.0"},{"groupId":"OG002","value":"2156.0","lowerLimit":"1340.0","upperLimit":"2611.0"},{"groupId":"OG003","value":"1308.5","lowerLimit":"774.0","upperLimit":"2052.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 157[N=17,21,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1924.0","lowerLimit":"1331.0","upperLimit":"2549.0"},{"groupId":"OG001","value":"1468.0","lowerLimit":"1210.0","upperLimit":"1972.0"},{"groupId":"OG002","value":"1836.0","lowerLimit":"1379.5","upperLimit":"3092.0"},{"groupId":"OG003","value":"1510.0","lowerLimit":"842.0","upperLimit":"1920.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 164[N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1870.0","lowerLimit":"1288.5","upperLimit":"2622.0"},{"groupId":"OG001","value":"1287.0","lowerLimit":"850.0","upperLimit":"2133.0"},{"groupId":"OG002","value":"2167.0","lowerLimit":"1676.0","upperLimit":"3672.0"},{"groupId":"OG003","value":"1251.0","lowerLimit":"898.0","upperLimit":"1820.0"}]}]},{"title":"A/Uruguay, CD4 All doubles, Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1662.0","lowerLimit":"1162.0","upperLimit":"2129.0"},{"groupId":"OG001","value":"1524.5","lowerLimit":"969.5","upperLimit":"1800.5"},{"groupId":"OG002","value":"1340.0","lowerLimit":"1153.0","upperLimit":"1901.0"},{"groupId":"OG003","value":"1226.0","lowerLimit":"923.0","upperLimit":"1901.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 125[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1416.5","lowerLimit":"874.0","upperLimit":"2264.0"},{"groupId":"OG001","value":"1310.0","lowerLimit":"910.0","upperLimit":"1525.0"},{"groupId":"OG002","value":"1574.5","lowerLimit":"840.0","upperLimit":"2334.5"},{"groupId":"OG003","value":"993.0","lowerLimit":"698.0","upperLimit":"1462.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 129[N=17,24,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1706.0","lowerLimit":"1199.0","upperLimit":"2371.0"},{"groupId":"OG001","value":"1429.5","lowerLimit":"1104.5","upperLimit":"2011.0"},{"groupId":"OG002","value":"1491.0","lowerLimit":"667.0","upperLimit":"2784.0"},{"groupId":"OG003","value":"1103.5","lowerLimit":"715.0","upperLimit":"1674.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 136[N=18,25,19,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2205.0","lowerLimit":"1308.0","upperLimit":"2793.0"},{"groupId":"OG001","value":"1484.0","lowerLimit":"1267.0","upperLimit":"1759.0"},{"groupId":"OG002","value":"1502.0","lowerLimit":"591.0","upperLimit":"2609.0"},{"groupId":"OG003","value":"1130.0","lowerLimit":"937.0","upperLimit":"2025.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 143[N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1596.5","lowerLimit":"1269.0","upperLimit":"2477.5"},{"groupId":"OG001","value":"1665.0","lowerLimit":"990.0","upperLimit":"2345.0"},{"groupId":"OG002","value":"1499.5","lowerLimit":"1012.0","upperLimit":"2851.5"},{"groupId":"OG003","value":"1351.5","lowerLimit":"1123.0","upperLimit":"2112.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 150[N=16,20,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1851.5","lowerLimit":"983.0","upperLimit":"2221.5"},{"groupId":"OG001","value":"1612.0","lowerLimit":"1365.5","upperLimit":"2014.5"},{"groupId":"OG002","value":"1448.0","lowerLimit":"845.0","upperLimit":"2483.0"},{"groupId":"OG003","value":"1324.5","lowerLimit":"727.0","upperLimit":"1884.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1945.0","lowerLimit":"1225.0","upperLimit":"2469.0"},{"groupId":"OG001","value":"1646.5","lowerLimit":"1053.0","upperLimit":"1946.0"},{"groupId":"OG002","value":"1951.5","lowerLimit":"938.0","upperLimit":"2794.5"},{"groupId":"OG003","value":"1334.5","lowerLimit":"937.0","upperLimit":"2001.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 164[N=16,19,19,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1734.5","lowerLimit":"959.0","upperLimit":"2300.0"},{"groupId":"OG001","value":"1422.0","lowerLimit":"1024.0","upperLimit":"2265.0"},{"groupId":"OG002","value":"2075.0","lowerLimit":"1257.0","upperLimit":"3193.0"},{"groupId":"OG003","value":"1272.0","lowerLimit":"891.0","upperLimit":"1687.0"}]}]},{"title":"B/Brisbane, CD4 All doubles,Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1837.0","lowerLimit":"1345.0","upperLimit":"2262.0"},{"groupId":"OG001","value":"1751.0","lowerLimit":"1229.0","upperLimit":"2468.5"},{"groupId":"OG002","value":"1398.0","lowerLimit":"875.0","upperLimit":"2572.0"},{"groupId":"OG003","value":"1602.0","lowerLimit":"976.0","upperLimit":"2618.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day125[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1489.5","lowerLimit":"959.0","upperLimit":"1994.0"},{"groupId":"OG001","value":"1627.5","lowerLimit":"1049.0","upperLimit":"2009.0"},{"groupId":"OG002","value":"1220.5","lowerLimit":"716.5","upperLimit":"1525.5"},{"groupId":"OG003","value":"1174.0","lowerLimit":"881.0","upperLimit":"1904.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day129[N=17,25,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1525.0","lowerLimit":"1382.0","upperLimit":"2289.0"},{"groupId":"OG001","value":"2009.0","lowerLimit":"1262.0","upperLimit":"2236.0"},{"groupId":"OG002","value":"1788.0","lowerLimit":"1278.0","upperLimit":"2626.0"},{"groupId":"OG003","value":"1772.5","lowerLimit":"1143.0","upperLimit":"2472.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day136[N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2263.0","lowerLimit":"1599.0","upperLimit":"3411.0"},{"groupId":"OG001","value":"2049.5","lowerLimit":"1752.5","upperLimit":"2955.5"},{"groupId":"OG002","value":"2292.5","lowerLimit":"1621.5","upperLimit":"4108.0"},{"groupId":"OG003","value":"2071.0","lowerLimit":"1368.0","upperLimit":"2922.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day143[N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2178.0","lowerLimit":"1407.0","upperLimit":"2937.0"},{"groupId":"OG001","value":"2123.0","lowerLimit":"1663.0","upperLimit":"3014.0"},{"groupId":"OG002","value":"2322.5","lowerLimit":"1744.0","upperLimit":"3598.5"},{"groupId":"OG003","value":"1906.0","lowerLimit":"1465.0","upperLimit":"2396.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day150[N=16,22,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2217.0","lowerLimit":"1612.5","upperLimit":"2837.0"},{"groupId":"OG001","value":"2059.0","lowerLimit":"1557.0","upperLimit":"2434.0"},{"groupId":"OG002","value":"2734.0","lowerLimit":"1658.0","upperLimit":"3914.0"},{"groupId":"OG003","value":"1954.0","lowerLimit":"1140.0","upperLimit":"2439.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2913.0","lowerLimit":"2049.0","upperLimit":"3616.0"},{"groupId":"OG001","value":"1943.5","lowerLimit":"1539.0","upperLimit":"2537.0"},{"groupId":"OG002","value":"2422.5","lowerLimit":"1896.5","upperLimit":"3805.0"},{"groupId":"OG003","value":"2129.0","lowerLimit":"1504.0","upperLimit":"2552.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day164[N=16,20,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"2518.0","lowerLimit":"1305.5","upperLimit":"3585.0"},{"groupId":"OG001","value":"2125.5","lowerLimit":"1591.5","upperLimit":"2707.0"},{"groupId":"OG002","value":"2579.0","lowerLimit":"1760.0","upperLimit":"4064.0"},{"groupId":"OG003","value":"1795.0","lowerLimit":"1133.0","upperLimit":"2244.0"}]}]},{"title":"A/Brisbane, CD4 Double CD40L,Day304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1889.5","lowerLimit":"1559.0","upperLimit":"2633.0"},{"groupId":"OG001","value":"1843.5","lowerLimit":"1340.5","upperLimit":"2315.0"},{"groupId":"OG002","value":"1989.0","lowerLimit":"1488.0","upperLimit":"2554.0"},{"groupId":"OG003","value":"1664.0","lowerLimit":"1094.0","upperLimit":"2274.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day125[N=14,21,15,17","categories":[{"measurements":[{"groupId":"OG000","value":"972.0","lowerLimit":"536.0","upperLimit":"1315.0"},{"groupId":"OG001","value":"900.0","lowerLimit":"730.0","upperLimit":"1371.0"},{"groupId":"OG002","value":"948.0","lowerLimit":"391.0","upperLimit":"1161.0"},{"groupId":"OG003","value":"1072.0","lowerLimit":"577.0","upperLimit":"1257.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day129[N=17,26,23,22","categories":[{"measurements":[{"groupId":"OG000","value":"1166.0","lowerLimit":"888.0","upperLimit":"1676.0"},{"groupId":"OG001","value":"1376.0","lowerLimit":"823.0","upperLimit":"1647.0"},{"groupId":"OG002","value":"1438.0","lowerLimit":"844.0","upperLimit":"2307.0"},{"groupId":"OG003","value":"1236.5","lowerLimit":"853.0","upperLimit":"1684.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day136[N=18,24,20,22","categories":[{"measurements":[{"groupId":"OG000","value":"1921.0","lowerLimit":"1353.0","upperLimit":"2394.0"},{"groupId":"OG001","value":"1486.0","lowerLimit":"1090.5","upperLimit":"1831.5"},{"groupId":"OG002","value":"2323.5","lowerLimit":"1712.0","upperLimit":"3753.0"},{"groupId":"OG003","value":"1559.0","lowerLimit":"835.0","upperLimit":"2269.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day143[N=17,27,20,18","categories":[{"measurements":[{"groupId":"OG000","value":"1613.0","lowerLimit":"1180.0","upperLimit":"2137.0"},{"groupId":"OG001","value":"1626.0","lowerLimit":"1029.0","upperLimit":"2089.0"},{"groupId":"OG002","value":"2264.0","lowerLimit":"1579.0","upperLimit":"3809.0"},{"groupId":"OG003","value":"1605.0","lowerLimit":"990.0","upperLimit":"1982.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day150[N=16,22,23,21","categories":[{"measurements":[{"groupId":"OG000","value":"2278.0","lowerLimit":"1592.5","upperLimit":"3258.0"},{"groupId":"OG001","value":"1547.5","lowerLimit":"1319.0","upperLimit":"1824.0"},{"groupId":"OG002","value":"2995.0","lowerLimit":"1856.0","upperLimit":"4618.0"},{"groupId":"OG003","value":"1568.0","lowerLimit":"702.0","upperLimit":"1769.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day157[N=17,22,20,18","categories":[{"measurements":[{"groupId":"OG000","value":"2276.0","lowerLimit":"1897.0","upperLimit":"2894.0"},{"groupId":"OG001","value":"1544.0","lowerLimit":"1068.0","upperLimit":"1819.0"},{"groupId":"OG002","value":"2662.0","lowerLimit":"1969.5","upperLimit":"3735.0"},{"groupId":"OG003","value":"1284.5","lowerLimit":"912.0","upperLimit":"1937.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day164[N=16,19,19,21","categories":[{"measurements":[{"groupId":"OG000","value":"2057.0","lowerLimit":"1309.0","upperLimit":"2687.0"},{"groupId":"OG001","value":"1553.0","lowerLimit":"916.0","upperLimit":"2100.0"},{"groupId":"OG002","value":"2443.0","lowerLimit":"1934.0","upperLimit":"4928.0"},{"groupId":"OG003","value":"1215.0","lowerLimit":"738.0","upperLimit":"1337.0"}]}]},{"title":"A/California,CD4 Double CD40L,Day304[N=18,28,19,27","categories":[{"measurements":[{"groupId":"OG000","value":"1537.0","lowerLimit":"1266.0","upperLimit":"2060.0"},{"groupId":"OG001","value":"1329.0","lowerLimit":"1116.5","upperLimit":"1740.0"},{"groupId":"OG002","value":"1770.0","lowerLimit":"1174.0","upperLimit":"2306.0"},{"groupId":"OG003","value":"1144.0","lowerLimit":"729.0","upperLimit":"1626.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 125 [N=14,21,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1115.0","lowerLimit":"617.0","upperLimit":"1782.0"},{"groupId":"OG001","value":"1040.0","lowerLimit":"753.0","upperLimit":"1302.0"},{"groupId":"OG002","value":"845.0","lowerLimit":"408.0","upperLimit":"1486.0"},{"groupId":"OG003","value":"963.0","lowerLimit":"562.0","upperLimit":"1288.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 129 [N=17,26,21,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1303.0","lowerLimit":"813.0","upperLimit":"1629.0"},{"groupId":"OG001","value":"1075.0","lowerLimit":"717.0","upperLimit":"1742.0"},{"groupId":"OG002","value":"1096.0","lowerLimit":"865.0","upperLimit":"1693.0"},{"groupId":"OG003","value":"1069.5","lowerLimit":"716.0","upperLimit":"1343.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 136 [N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1596.5","lowerLimit":"1081.0","upperLimit":"2063.0"},{"groupId":"OG001","value":"1426.0","lowerLimit":"1022.0","upperLimit":"1720.0"},{"groupId":"OG002","value":"1546.0","lowerLimit":"1061.0","upperLimit":"2284.5"},{"groupId":"OG003","value":"1401.0","lowerLimit":"823.0","upperLimit":"1847.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 143 [N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1465.5","lowerLimit":"947.5","upperLimit":"1934.5"},{"groupId":"OG001","value":"1454.0","lowerLimit":"1001.0","upperLimit":"1703.0"},{"groupId":"OG002","value":"1753.0","lowerLimit":"1243.5","upperLimit":"2347.5"},{"groupId":"OG003","value":"1175.5","lowerLimit":"849.0","upperLimit":"1564.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 150 [N=16,21,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1752.5","lowerLimit":"1020.0","upperLimit":"2302.0"},{"groupId":"OG001","value":"1214.0","lowerLimit":"1092.0","upperLimit":"1582.0"},{"groupId":"OG002","value":"1800.0","lowerLimit":"1141.0","upperLimit":"2225.0"},{"groupId":"OG003","value":"1250.0","lowerLimit":"677.0","upperLimit":"1819.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 157 [N=17,21,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1796.0","lowerLimit":"1252.0","upperLimit":"2291.0"},{"groupId":"OG001","value":"1321.0","lowerLimit":"1013.0","upperLimit":"1894.0"},{"groupId":"OG002","value":"1662.0","lowerLimit":"1188.0","upperLimit":"2805.5"},{"groupId":"OG003","value":"1190.0","lowerLimit":"731.0","upperLimit":"1844.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 164 [N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1663.0","lowerLimit":"1136.5","upperLimit":"2349.5"},{"groupId":"OG001","value":"1250.0","lowerLimit":"800.0","upperLimit":"1947.0"},{"groupId":"OG002","value":"1780.0","lowerLimit":"1325.0","upperLimit":"2532.0"},{"groupId":"OG003","value":"1083.0","lowerLimit":"785.0","upperLimit":"1526.0"}]}]},{"title":"A/Uruguay,CD4 Double CD40L,Day 304 [N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1551.5","lowerLimit":"1126.0","upperLimit":"1971.0"},{"groupId":"OG001","value":"1440.5","lowerLimit":"944.0","upperLimit":"1720.5"},{"groupId":"OG002","value":"1267.0","lowerLimit":"979.0","upperLimit":"1783.0"},{"groupId":"OG003","value":"1131.0","lowerLimit":"847.0","upperLimit":"1766.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 125[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1302.0","lowerLimit":"880.0","upperLimit":"2070.0"},{"groupId":"OG001","value":"1221.5","lowerLimit":"843.0","upperLimit":"1428.0"},{"groupId":"OG002","value":"1299.0","lowerLimit":"777.0","upperLimit":"1953.0"},{"groupId":"OG003","value":"877.0","lowerLimit":"670.0","upperLimit":"1361.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 129[N=17,24,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1555.0","lowerLimit":"1037.0","upperLimit":"2269.0"},{"groupId":"OG001","value":"1336.5","lowerLimit":"984.0","upperLimit":"1825.5"},{"groupId":"OG002","value":"1106.0","lowerLimit":"619.0","upperLimit":"1973.0"},{"groupId":"OG003","value":"962.5","lowerLimit":"700.0","upperLimit":"1536.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 136[N=18,25,19,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1966.5","lowerLimit":"1197.0","upperLimit":"2468.0"},{"groupId":"OG001","value":"1372.0","lowerLimit":"1014.0","upperLimit":"1636.0"},{"groupId":"OG002","value":"1433.0","lowerLimit":"573.0","upperLimit":"2262.0"},{"groupId":"OG003","value":"1096.5","lowerLimit":"767.0","upperLimit":"1832.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 143[N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1348.0","lowerLimit":"1114.0","upperLimit":"2231.0"},{"groupId":"OG001","value":"1511.0","lowerLimit":"951.0","upperLimit":"2084.0"},{"groupId":"OG002","value":"1399.5","lowerLimit":"919.0","upperLimit":"2504.5"},{"groupId":"OG003","value":"1153.5","lowerLimit":"1030.0","upperLimit":"1627.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 150[N=16,20,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1697.0","lowerLimit":"845.5","upperLimit":"1966.5"},{"groupId":"OG001","value":"1342.5","lowerLimit":"1088.0","upperLimit":"1703.0"},{"groupId":"OG002","value":"1358.0","lowerLimit":"795.0","upperLimit":"2205.0"},{"groupId":"OG003","value":"1142.0","lowerLimit":"708.0","upperLimit":"1619.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1700.0","lowerLimit":"1073.0","upperLimit":"2170.0"},{"groupId":"OG001","value":"1497.5","lowerLimit":"888.0","upperLimit":"1834.0"},{"groupId":"OG002","value":"1565.5","lowerLimit":"873.5","upperLimit":"2389.5"},{"groupId":"OG003","value":"1213.0","lowerLimit":"817.0","upperLimit":"1738.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 164[N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1564.0","lowerLimit":"826.5","upperLimit":"2136.0"},{"groupId":"OG001","value":"1306.0","lowerLimit":"1018.0","upperLimit":"2145.0"},{"groupId":"OG002","value":"1751.0","lowerLimit":"1078.0","upperLimit":"2735.0"},{"groupId":"OG003","value":"1005.0","lowerLimit":"839.0","upperLimit":"1451.0"}]}]},{"title":"B/Brisbane,CD4 Double CD40L,Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1790.0","lowerLimit":"1293.0","upperLimit":"2074.0"},{"groupId":"OG001","value":"1616.5","lowerLimit":"1174.0","upperLimit":"2291.5"},{"groupId":"OG002","value":"1305.0","lowerLimit":"887.0","upperLimit":"2400.0"},{"groupId":"OG003","value":"1599.0","lowerLimit":"870.0","upperLimit":"2316.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 125[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1293.5","lowerLimit":"675.0","upperLimit":"1829.0"},{"groupId":"OG001","value":"1273.5","lowerLimit":"905.0","upperLimit":"1699.0"},{"groupId":"OG002","value":"975.0","lowerLimit":"470.0","upperLimit":"1576.0"},{"groupId":"OG003","value":"884.0","lowerLimit":"671.0","upperLimit":"1589.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 129[N=17,25,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1482.0","lowerLimit":"1181.0","upperLimit":"2157.0"},{"groupId":"OG001","value":"1606.0","lowerLimit":"1163.0","upperLimit":"2145.0"},{"groupId":"OG002","value":"1497.0","lowerLimit":"1210.0","upperLimit":"2862.0"},{"groupId":"OG003","value":"1608.5","lowerLimit":"1091.0","upperLimit":"2305.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 136[N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1944.0","lowerLimit":"1389.0","upperLimit":"2979.0"},{"groupId":"OG001","value":"1791.0","lowerLimit":"1354.5","upperLimit":"2312.5"},{"groupId":"OG002","value":"2037.5","lowerLimit":"1450.5","upperLimit":"3850.0"},{"groupId":"OG003","value":"1681.5","lowerLimit":"1084.0","upperLimit":"2360.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 143[N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1630.0","lowerLimit":"1331.0","upperLimit":"2537.0"},{"groupId":"OG001","value":"1833.0","lowerLimit":"1452.0","upperLimit":"2494.0"},{"groupId":"OG002","value":"1899.0","lowerLimit":"1301.5","upperLimit":"3191.5"},{"groupId":"OG003","value":"1639.5","lowerLimit":"1313.0","upperLimit":"2232.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 150[N=16,22,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2150.0","lowerLimit":"1623.5","upperLimit":"2774.5"},{"groupId":"OG001","value":"1801.5","lowerLimit":"1360.0","upperLimit":"2157.0"},{"groupId":"OG002","value":"2335.0","lowerLimit":"1497.0","upperLimit":"3505.0"},{"groupId":"OG003","value":"1815.0","lowerLimit":"1173.0","upperLimit":"2268.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2247.0","lowerLimit":"2015.0","upperLimit":"2732.0"},{"groupId":"OG001","value":"1809.0","lowerLimit":"1416.0","upperLimit":"2269.0"},{"groupId":"OG002","value":"2234.5","lowerLimit":"1603.0","upperLimit":"3188.5"},{"groupId":"OG003","value":"1774.0","lowerLimit":"1183.0","upperLimit":"2242.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 164[N=16,20,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"2208.5","lowerLimit":"1301.0","upperLimit":"3058.5"},{"groupId":"OG001","value":"1617.5","lowerLimit":"1318.5","upperLimit":"2253.0"},{"groupId":"OG002","value":"2446.0","lowerLimit":"1488.0","upperLimit":"3608.0"},{"groupId":"OG003","value":"1292.0","lowerLimit":"1041.0","upperLimit":"1972.0"}]}]},{"title":"A/Brisbane,CD4 Double IFNg, Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1748.0","lowerLimit":"1147.0","upperLimit":"2200.0"},{"groupId":"OG001","value":"1551.5","lowerLimit":"1107.0","upperLimit":"1893.5"},{"groupId":"OG002","value":"1531.0","lowerLimit":"1043.0","upperLimit":"2590.0"},{"groupId":"OG003","value":"1301.0","lowerLimit":"897.0","upperLimit":"1821.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 125[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"753.0","lowerLimit":"365.0","upperLimit":"1120.0"},{"groupId":"OG001","value":"832.0","lowerLimit":"623.0","upperLimit":"1029.0"},{"groupId":"OG002","value":"735.0","lowerLimit":"361.0","upperLimit":"1357.0"},{"groupId":"OG003","value":"748.0","lowerLimit":"603.0","upperLimit":"1087.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 129[N=17,26,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1155.0","lowerLimit":"744.0","upperLimit":"1413.0"},{"groupId":"OG001","value":"1100.5","lowerLimit":"787.0","upperLimit":"1504.0"},{"groupId":"OG002","value":"1469.0","lowerLimit":"905.0","upperLimit":"2318.0"},{"groupId":"OG003","value":"1147.5","lowerLimit":"809.0","upperLimit":"1715.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 136[N=18,24,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1548.5","lowerLimit":"1059.0","upperLimit":"2077.0"},{"groupId":"OG001","value":"1321.0","lowerLimit":"1118.5","upperLimit":"1516.5"},{"groupId":"OG002","value":"1752.0","lowerLimit":"1379.5","upperLimit":"3541.0"},{"groupId":"OG003","value":"1266.0","lowerLimit":"743.0","upperLimit":"2149.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 143[N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1267.0","lowerLimit":"921.0","upperLimit":"1950.0"},{"groupId":"OG001","value":"1188.0","lowerLimit":"870.0","upperLimit":"1829.0"},{"groupId":"OG002","value":"1583.5","lowerLimit":"969.0","upperLimit":"3473.5"},{"groupId":"OG003","value":"1388.5","lowerLimit":"1099.0","upperLimit":"1731.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 150[N=16,23,22,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1828.5","lowerLimit":"1200.5","upperLimit":"2095.0"},{"groupId":"OG001","value":"1417.0","lowerLimit":"1212.0","upperLimit":"1599.0"},{"groupId":"OG002","value":"2118.0","lowerLimit":"1271.0","upperLimit":"3433.0"},{"groupId":"OG003","value":"1173.0","lowerLimit":"835.0","upperLimit":"1687.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1771.0","lowerLimit":"1618.0","upperLimit":"2164.0"},{"groupId":"OG001","value":"1265.5","lowerLimit":"972.0","upperLimit":"1693.0"},{"groupId":"OG002","value":"2080.0","lowerLimit":"1445.0","upperLimit":"2854.0"},{"groupId":"OG003","value":"1101.5","lowerLimit":"763.0","upperLimit":"1620.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 164[N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1715.5","lowerLimit":"1249.5","upperLimit":"2281.0"},{"groupId":"OG001","value":"1320.0","lowerLimit":"954.0","upperLimit":"1681.0"},{"groupId":"OG002","value":"2444.0","lowerLimit":"1259.0","upperLimit":"3564.0"},{"groupId":"OG003","value":"1031.0","lowerLimit":"696.0","upperLimit":"1312.0"}]}]},{"title":"A/California,CD4Double IFNg,Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1105.0","lowerLimit":"950.0","upperLimit":"1666.0"},{"groupId":"OG001","value":"1129.0","lowerLimit":"919.0","upperLimit":"1522.0"},{"groupId":"OG002","value":"1351.0","lowerLimit":"816.0","upperLimit":"2229.0"},{"groupId":"OG003","value":"1107.0","lowerLimit":"730.0","upperLimit":"1422.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 125 [N=14,21,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"798.0","lowerLimit":"493.0","upperLimit":"1462.0"},{"groupId":"OG001","value":"791.0","lowerLimit":"676.0","upperLimit":"1032.0"},{"groupId":"OG002","value":"965.5","lowerLimit":"320.5","upperLimit":"1392.5"},{"groupId":"OG003","value":"882.0","lowerLimit":"509.0","upperLimit":"1013.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 129 [N=17,26,21,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1067.0","lowerLimit":"780.0","upperLimit":"1561.0"},{"groupId":"OG001","value":"1012.0","lowerLimit":"708.0","upperLimit":"1417.0"},{"groupId":"OG002","value":"1061.0","lowerLimit":"803.0","upperLimit":"1614.0"},{"groupId":"OG003","value":"958.5","lowerLimit":"615.0","upperLimit":"1504.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 136 [N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1429.0","lowerLimit":"926.0","upperLimit":"1908.0"},{"groupId":"OG001","value":"1142.5","lowerLimit":"740.0","upperLimit":"1531.0"},{"groupId":"OG002","value":"1390.0","lowerLimit":"922.5","upperLimit":"2068.0"},{"groupId":"OG003","value":"1198.5","lowerLimit":"560.0","upperLimit":"1665.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 143 [N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1395.5","lowerLimit":"834.0","upperLimit":"1811.0"},{"groupId":"OG001","value":"1216.0","lowerLimit":"872.0","upperLimit":"1486.0"},{"groupId":"OG002","value":"1575.5","lowerLimit":"864.0","upperLimit":"2056.0"},{"groupId":"OG003","value":"1171.0","lowerLimit":"858.0","upperLimit":"1363.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 150 [N=16,21,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1473.5","lowerLimit":"897.0","upperLimit":"2076.0"},{"groupId":"OG001","value":"1234.0","lowerLimit":"963.0","upperLimit":"1461.0"},{"groupId":"OG002","value":"1561.0","lowerLimit":"1086.0","upperLimit":"2500.0"},{"groupId":"OG003","value":"1104.0","lowerLimit":"748.0","upperLimit":"1502.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 157 [N=17,21,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1709.0","lowerLimit":"1081.0","upperLimit":"2118.0"},{"groupId":"OG001","value":"1220.0","lowerLimit":"803.0","upperLimit":"1502.0"},{"groupId":"OG002","value":"1435.0","lowerLimit":"1029.5","upperLimit":"2182.5"},{"groupId":"OG003","value":"1088.0","lowerLimit":"632.0","upperLimit":"1483.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 164 [N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1476.5","lowerLimit":"1119.0","upperLimit":"2194.0"},{"groupId":"OG001","value":"1105.0","lowerLimit":"799.0","upperLimit":"1632.0"},{"groupId":"OG002","value":"1688.0","lowerLimit":"1265.0","upperLimit":"2239.0"},{"groupId":"OG003","value":"1090.0","lowerLimit":"524.0","upperLimit":"1473.0"}]}]},{"title":"A/Uruguay,CD4 Double IFNg,Day 304 [N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1281.5","lowerLimit":"862.0","upperLimit":"1806.0"},{"groupId":"OG001","value":"1113.0","lowerLimit":"836.5","upperLimit":"1477.5"},{"groupId":"OG002","value":"1015.0","lowerLimit":"848.0","upperLimit":"1402.0"},{"groupId":"OG003","value":"1089.0","lowerLimit":"683.0","upperLimit":"1392.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 125 [N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1050.0","lowerLimit":"742.0","upperLimit":"1909.0"},{"groupId":"OG001","value":"1022.5","lowerLimit":"873.0","upperLimit":"1451.0"},{"groupId":"OG002","value":"1377.5","lowerLimit":"784.5","upperLimit":"2093.0"},{"groupId":"OG003","value":"964.0","lowerLimit":"832.0","upperLimit":"1243.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 129 [N=17,24,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1391.0","lowerLimit":"824.0","upperLimit":"1959.0"},{"groupId":"OG001","value":"1178.5","lowerLimit":"1030.5","upperLimit":"1547.0"},{"groupId":"OG002","value":"1308.0","lowerLimit":"604.0","upperLimit":"2350.0"},{"groupId":"OG003","value":"1008.0","lowerLimit":"775.0","upperLimit":"1404.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 136 [N=18,25,19,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1694.0","lowerLimit":"1075.0","upperLimit":"2394.0"},{"groupId":"OG001","value":"1253.0","lowerLimit":"899.0","upperLimit":"1446.0"},{"groupId":"OG002","value":"1248.0","lowerLimit":"582.0","upperLimit":"2389.0"},{"groupId":"OG003","value":"1008.5","lowerLimit":"825.0","upperLimit":"1864.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 143 [N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1311.0","lowerLimit":"867.5","upperLimit":"2027.0"},{"groupId":"OG001","value":"1293.0","lowerLimit":"969.0","upperLimit":"1716.0"},{"groupId":"OG002","value":"1205.0","lowerLimit":"707.0","upperLimit":"2490.0"},{"groupId":"OG003","value":"1252.0","lowerLimit":"885.0","upperLimit":"1818.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 150 [N=16,20,22,23]","categories":[{"measurements":[{"groupId":"OG000","value":"1410.0","lowerLimit":"848.5","upperLimit":"1843.5"},{"groupId":"OG001","value":"1359.5","lowerLimit":"1041.0","upperLimit":"1684.5"},{"groupId":"OG002","value":"1362.0","lowerLimit":"699.0","upperLimit":"2082.0"},{"groupId":"OG003","value":"1174.5","lowerLimit":"674.0","upperLimit":"1503.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 157 [N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1397.0","lowerLimit":"1057.0","upperLimit":"1958.0"},{"groupId":"OG001","value":"1417.0","lowerLimit":"930.0","upperLimit":"1723.0"},{"groupId":"OG002","value":"1514.0","lowerLimit":"689.0","upperLimit":"2352.5"},{"groupId":"OG003","value":"1145.5","lowerLimit":"742.0","upperLimit":"1805.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 164 [N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1477.5","lowerLimit":"863.5","upperLimit":"2214.0"},{"groupId":"OG001","value":"1166.0","lowerLimit":"927.0","upperLimit":"1558.0"},{"groupId":"OG002","value":"1540.0","lowerLimit":"856.0","upperLimit":"2808.0"},{"groupId":"OG003","value":"1088.0","lowerLimit":"749.0","upperLimit":"1418.0"}]}]},{"title":"B/Brisbane,CD4 Double IFNg,Day 304 [N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1471.0","lowerLimit":"1000.0","upperLimit":"2137.0"},{"groupId":"OG001","value":"1337.5","lowerLimit":"964.0","upperLimit":"2236.0"},{"groupId":"OG002","value":"1189.0","lowerLimit":"656.0","upperLimit":"1903.0"},{"groupId":"OG003","value":"1398.0","lowerLimit":"714.0","upperLimit":"2317.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 125 [N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1229.0","lowerLimit":"764.0","upperLimit":"1776.0"},{"groupId":"OG001","value":"1343.0","lowerLimit":"851.0","upperLimit":"1900.0"},{"groupId":"OG002","value":"1099.5","lowerLimit":"521.5","upperLimit":"1522.5"},{"groupId":"OG003","value":"1038.0","lowerLimit":"701.0","upperLimit":"1474.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 129 [N=17,25,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1331.0","lowerLimit":"1223.0","upperLimit":"2042.0"},{"groupId":"OG001","value":"1844.0","lowerLimit":"1144.0","upperLimit":"2035.0"},{"groupId":"OG002","value":"1697.0","lowerLimit":"1167.0","upperLimit":"2782.0"},{"groupId":"OG003","value":"1629.5","lowerLimit":"1019.0","upperLimit":"2114.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 136 [N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2051.0","lowerLimit":"1699.0","upperLimit":"3124.0"},{"groupId":"OG001","value":"1933.0","lowerLimit":"1539.5","upperLimit":"2477.0"},{"groupId":"OG002","value":"2153.0","lowerLimit":"1709.0","upperLimit":"3553.0"},{"groupId":"OG003","value":"2009.5","lowerLimit":"1400.0","upperLimit":"2698.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 143 [N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1922.0","lowerLimit":"1339.0","upperLimit":"2564.0"},{"groupId":"OG001","value":"2045.0","lowerLimit":"1486.0","upperLimit":"2862.0"},{"groupId":"OG002","value":"2246.0","lowerLimit":"1605.5","upperLimit":"3199.0"},{"groupId":"OG003","value":"1891.0","lowerLimit":"1431.0","upperLimit":"2179.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 150 [N=16,22,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2189.5","lowerLimit":"1457.5","upperLimit":"2654.5"},{"groupId":"OG001","value":"1891.0","lowerLimit":"1415.0","upperLimit":"2342.0"},{"groupId":"OG002","value":"2771.0","lowerLimit":"1724.0","upperLimit":"3806.0"},{"groupId":"OG003","value":"1908.5","lowerLimit":"1337.0","upperLimit":"2430.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 157 [N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2407.0","lowerLimit":"1867.0","upperLimit":"3146.0"},{"groupId":"OG001","value":"1816.5","lowerLimit":"1284.0","upperLimit":"2592.0"},{"groupId":"OG002","value":"2512.0","lowerLimit":"2137.0","upperLimit":"3579.5"},{"groupId":"OG003","value":"1968.5","lowerLimit":"1285.0","upperLimit":"2275.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 164 [N=16,20,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"2561.5","lowerLimit":"1249.0","upperLimit":"3414.0"},{"groupId":"OG001","value":"1956.5","lowerLimit":"1237.5","upperLimit":"2546.0"},{"groupId":"OG002","value":"2536.0","lowerLimit":"1827.0","upperLimit":"3889.0"},{"groupId":"OG003","value":"1546.0","lowerLimit":"1106.0","upperLimit":"1881.0"}]}]},{"title":"A/Brisbane,CD4 Double IL-2,Day 304 [N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1665.0","lowerLimit":"1304.0","upperLimit":"2382.0"},{"groupId":"OG001","value":"1592.5","lowerLimit":"1317.0","upperLimit":"2049.5"},{"groupId":"OG002","value":"1884.0","lowerLimit":"1329.0","upperLimit":"2490.0"},{"groupId":"OG003","value":"1460.0","lowerLimit":"1103.0","upperLimit":"2038.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day125[N=14,21,15,17]","categories":[{"measurements":[{"groupId":"OG000","value":"882.0","lowerLimit":"578.0","upperLimit":"1314.0"},{"groupId":"OG001","value":"986.0","lowerLimit":"765.0","upperLimit":"1061.0"},{"groupId":"OG002","value":"925.0","lowerLimit":"314.0","upperLimit":"1300.0"},{"groupId":"OG003","value":"937.0","lowerLimit":"491.0","upperLimit":"1321.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day129[N=17,26,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1209.0","lowerLimit":"966.0","upperLimit":"1456.0"},{"groupId":"OG001","value":"1206.0","lowerLimit":"851.0","upperLimit":"1576.0"},{"groupId":"OG002","value":"1506.0","lowerLimit":"952.0","upperLimit":"2525.0"},{"groupId":"OG003","value":"1144.0","lowerLimit":"900.0","upperLimit":"1775.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day136[N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"2064.0","lowerLimit":"1403.0","upperLimit":"2270.0"},{"groupId":"OG001","value":"1496.5","lowerLimit":"1142.5","upperLimit":"1851.0"},{"groupId":"OG002","value":"2284.0","lowerLimit":"1730.0","upperLimit":"3903.5"},{"groupId":"OG003","value":"1558.0","lowerLimit":"885.0","upperLimit":"2116.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day143[N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1572.0","lowerLimit":"1098.0","upperLimit":"2060.0"},{"groupId":"OG001","value":"1538.0","lowerLimit":"1023.0","upperLimit":"1959.0"},{"groupId":"OG002","value":"2217.0","lowerLimit":"1649.0","upperLimit":"3774.0"},{"groupId":"OG003","value":"1500.0","lowerLimit":"1036.0","upperLimit":"1759.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day150[N=16,22,23,21]","categories":[{"measurements":[{"groupId":"OG000","value":"2168.0","lowerLimit":"1392.0","upperLimit":"3140.5"},{"groupId":"OG001","value":"1645.5","lowerLimit":"1387.0","upperLimit":"1810.0"},{"groupId":"OG002","value":"2915.0","lowerLimit":"1787.0","upperLimit":"4394.0"},{"groupId":"OG003","value":"1309.0","lowerLimit":"858.0","upperLimit":"1770.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2314.0","lowerLimit":"1892.0","upperLimit":"2880.0"},{"groupId":"OG001","value":"1559.0","lowerLimit":"1109.0","upperLimit":"1669.0"},{"groupId":"OG002","value":"2485.0","lowerLimit":"2039.0","upperLimit":"3925.5"},{"groupId":"OG003","value":"1337.0","lowerLimit":"968.0","upperLimit":"1743.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day164[N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"2162.0","lowerLimit":"1371.0","upperLimit":"2926.5"},{"groupId":"OG001","value":"1581.0","lowerLimit":"969.0","upperLimit":"2120.0"},{"groupId":"OG002","value":"2806.0","lowerLimit":"1997.0","upperLimit":"4641.0"},{"groupId":"OG003","value":"1134.0","lowerLimit":"911.0","upperLimit":"1444.0"}]}]},{"title":"A/California,CD4 Double IL-2,Day304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1441.5","lowerLimit":"1136.0","upperLimit":"2003.0"},{"groupId":"OG001","value":"1272.5","lowerLimit":"1081.5","upperLimit":"1715.0"},{"groupId":"OG002","value":"1778.0","lowerLimit":"1154.0","upperLimit":"2198.0"},{"groupId":"OG003","value":"1208.0","lowerLimit":"895.0","upperLimit":"1588.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 125 [N=14,21,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"916.0","lowerLimit":"566.0","upperLimit":"1489.0"},{"groupId":"OG001","value":"840.0","lowerLimit":"666.0","upperLimit":"1201.0"},{"groupId":"OG002","value":"900.0","lowerLimit":"415.0","upperLimit":"1384.0"},{"groupId":"OG003","value":"851.0","lowerLimit":"563.0","upperLimit":"1170.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 129 [N=17,26,21,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1189.0","lowerLimit":"730.0","upperLimit":"1391.0"},{"groupId":"OG001","value":"1037.0","lowerLimit":"732.0","upperLimit":"1583.0"},{"groupId":"OG002","value":"1100.0","lowerLimit":"885.0","upperLimit":"1619.0"},{"groupId":"OG003","value":"999.5","lowerLimit":"684.0","upperLimit":"1214.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 136 [N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1438.5","lowerLimit":"898.0","upperLimit":"1892.0"},{"groupId":"OG001","value":"1322.5","lowerLimit":"929.0","upperLimit":"1661.0"},{"groupId":"OG002","value":"1353.0","lowerLimit":"1072.5","upperLimit":"2192.5"},{"groupId":"OG003","value":"1290.0","lowerLimit":"852.0","upperLimit":"1633.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 143 [N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1359.5","lowerLimit":"895.5","upperLimit":"1821.5"},{"groupId":"OG001","value":"1255.0","lowerLimit":"878.0","upperLimit":"1674.0"},{"groupId":"OG002","value":"1642.0","lowerLimit":"1058.5","upperLimit":"2268.0"},{"groupId":"OG003","value":"1252.5","lowerLimit":"775.0","upperLimit":"1580.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 150 [N=16,21,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1575.5","lowerLimit":"920.5","upperLimit":"2231.5"},{"groupId":"OG001","value":"1158.0","lowerLimit":"954.0","upperLimit":"1641.0"},{"groupId":"OG002","value":"1739.0","lowerLimit":"1240.0","upperLimit":"2035.0"},{"groupId":"OG003","value":"1063.5","lowerLimit":"652.0","upperLimit":"1659.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 157 [N=17,21,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1691.0","lowerLimit":"1134.0","upperLimit":"2112.0"},{"groupId":"OG001","value":"1249.0","lowerLimit":"979.0","upperLimit":"1652.0"},{"groupId":"OG002","value":"1502.5","lowerLimit":"1187.5","upperLimit":"2649.5"},{"groupId":"OG003","value":"1199.0","lowerLimit":"757.0","upperLimit":"1721.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 164 [N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1545.0","lowerLimit":"1171.5","upperLimit":"2161.5"},{"groupId":"OG001","value":"1029.0","lowerLimit":"806.0","upperLimit":"1936.0"},{"groupId":"OG002","value":"1896.0","lowerLimit":"1416.0","upperLimit":"3324.0"},{"groupId":"OG003","value":"1028.0","lowerLimit":"826.0","upperLimit":"1405.0"}]}]},{"title":"A/Uruguay,CD4 Double IL-2,Day 304 [N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1392.5","lowerLimit":"977.0","upperLimit":"1737.0"},{"groupId":"OG001","value":"1317.0","lowerLimit":"873.0","upperLimit":"1575.0"},{"groupId":"OG002","value":"1165.0","lowerLimit":"991.0","upperLimit":"1720.0"},{"groupId":"OG003","value":"1054.0","lowerLimit":"741.0","upperLimit":"1683.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 125 [N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"1201.5","lowerLimit":"737.0","upperLimit":"1951.0"},{"groupId":"OG001","value":"1089.5","lowerLimit":"856.0","upperLimit":"1281.0"},{"groupId":"OG002","value":"1325.0","lowerLimit":"758.5","upperLimit":"2082.5"},{"groupId":"OG003","value":"855.0","lowerLimit":"599.0","upperLimit":"1188.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 129 [N=17,24,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1379.0","lowerLimit":"1019.0","upperLimit":"2132.0"},{"groupId":"OG001","value":"1257.0","lowerLimit":"942.5","upperLimit":"1722.0"},{"groupId":"OG002","value":"1238.0","lowerLimit":"587.0","upperLimit":"2297.0"},{"groupId":"OG003","value":"1055.5","lowerLimit":"611.0","upperLimit":"1530.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 136 [N=18,25,19,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1847.5","lowerLimit":"1146.0","upperLimit":"2304.0"},{"groupId":"OG001","value":"1290.0","lowerLimit":"946.0","upperLimit":"1536.0"},{"groupId":"OG002","value":"1312.0","lowerLimit":"429.0","upperLimit":"2399.0"},{"groupId":"OG003","value":"979.5","lowerLimit":"804.0","upperLimit":"1888.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 143 [N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1280.0","lowerLimit":"1107.5","upperLimit":"2110.0"},{"groupId":"OG001","value":"1381.0","lowerLimit":"907.0","upperLimit":"1931.0"},{"groupId":"OG002","value":"1280.0","lowerLimit":"833.5","upperLimit":"2419.5"},{"groupId":"OG003","value":"1117.0","lowerLimit":"922.0","upperLimit":"1935.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 150 [N=16,20,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1541.0","lowerLimit":"882.0","upperLimit":"1940.0"},{"groupId":"OG001","value":"1365.0","lowerLimit":"953.0","upperLimit":"1773.0"},{"groupId":"OG002","value":"1172.0","lowerLimit":"786.0","upperLimit":"1987.0"},{"groupId":"OG003","value":"1169.5","lowerLimit":"661.0","upperLimit":"1620.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 157 [N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1611.0","lowerLimit":"1220.0","upperLimit":"2031.0"},{"groupId":"OG001","value":"1299.5","lowerLimit":"901.0","upperLimit":"1621.0"},{"groupId":"OG002","value":"1587.0","lowerLimit":"857.5","upperLimit":"2291.5"},{"groupId":"OG003","value":"1068.5","lowerLimit":"871.0","upperLimit":"1596.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 164 [N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1478.5","lowerLimit":"840.0","upperLimit":"2005.5"},{"groupId":"OG001","value":"1191.0","lowerLimit":"814.0","upperLimit":"1955.0"},{"groupId":"OG002","value":"1597.0","lowerLimit":"1163.0","upperLimit":"2813.0"},{"groupId":"OG003","value":"1089.0","lowerLimit":"659.0","upperLimit":"1441.0"}]}]},{"title":"B/Brisbane,CD4 Double IL-2,Day 304 [N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1578.0","lowerLimit":"1144.0","upperLimit":"1908.0"},{"groupId":"OG001","value":"1374.0","lowerLimit":"1047.5","upperLimit":"2030.0"},{"groupId":"OG002","value":"1134.0","lowerLimit":"757.0","upperLimit":"2166.0"},{"groupId":"OG003","value":"1512.0","lowerLimit":"831.0","upperLimit":"2148.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 125 [N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"993.0","lowerLimit":"686.0","upperLimit":"1619.0"},{"groupId":"OG001","value":"1089.5","lowerLimit":"660.0","upperLimit":"1352.0"},{"groupId":"OG002","value":"962.0","lowerLimit":"437.0","upperLimit":"1385.5"},{"groupId":"OG003","value":"859.0","lowerLimit":"753.0","upperLimit":"1539.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 129 [N=17,25,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1257.0","lowerLimit":"859.0","upperLimit":"1687.0"},{"groupId":"OG001","value":"1313.0","lowerLimit":"1030.0","upperLimit":"1715.0"},{"groupId":"OG002","value":"1235.0","lowerLimit":"725.0","upperLimit":"2103.0"},{"groupId":"OG003","value":"1060.0","lowerLimit":"863.0","upperLimit":"1846.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 136 [N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1769.0","lowerLimit":"1275.0","upperLimit":"2758.0"},{"groupId":"OG001","value":"1575.0","lowerLimit":"1134.5","upperLimit":"2282.5"},{"groupId":"OG002","value":"1869.5","lowerLimit":"1148.5","upperLimit":"3179.5"},{"groupId":"OG003","value":"1288.5","lowerLimit":"1061.0","upperLimit":"2365.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 143 [N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1520.0","lowerLimit":"945.0","upperLimit":"2070.0"},{"groupId":"OG001","value":"1659.0","lowerLimit":"1026.0","upperLimit":"2276.0"},{"groupId":"OG002","value":"1672.5","lowerLimit":"1031.0","upperLimit":"2637.5"},{"groupId":"OG003","value":"1404.5","lowerLimit":"971.0","upperLimit":"2045.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 150 [N=16,22,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1761.0","lowerLimit":"1228.0","upperLimit":"2176.0"},{"groupId":"OG001","value":"1549.0","lowerLimit":"1014.0","upperLimit":"1952.0"},{"groupId":"OG002","value":"2260.0","lowerLimit":"1190.0","upperLimit":"3394.0"},{"groupId":"OG003","value":"1325.5","lowerLimit":"966.0","upperLimit":"2152.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 157 [N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2529.0","lowerLimit":"1589.0","upperLimit":"2887.0"},{"groupId":"OG001","value":"1485.5","lowerLimit":"1042.0","upperLimit":"1833.0"},{"groupId":"OG002","value":"2082.5","lowerLimit":"1522.5","upperLimit":"2970.5"},{"groupId":"OG003","value":"1392.5","lowerLimit":"875.0","upperLimit":"2079.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 164 [N=16,20,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1813.5","lowerLimit":"1043.5","upperLimit":"3072.0"},{"groupId":"OG001","value":"1476.5","lowerLimit":"903.5","upperLimit":"2081.5"},{"groupId":"OG002","value":"2372.0","lowerLimit":"1635.0","upperLimit":"3544.0"},{"groupId":"OG003","value":"1278.0","lowerLimit":"862.0","upperLimit":"1527.0"}]}]},{"title":"A/Brisbane,CD4 Double TNFa,Day 304 [N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1257.0","lowerLimit":"936.0","upperLimit":"2073.0"},{"groupId":"OG001","value":"1357.5","lowerLimit":"877.5","upperLimit":"1711.5"},{"groupId":"OG002","value":"1396.0","lowerLimit":"947.0","upperLimit":"2155.0"},{"groupId":"OG003","value":"1169.0","lowerLimit":"824.0","upperLimit":"1669.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 125[N=14,21,15,17]","categories":[{"measurements":[{"groupId":"OG000","value":"754.5","lowerLimit":"366.0","upperLimit":"1445.0"},{"groupId":"OG001","value":"777.0","lowerLimit":"601.0","upperLimit":"1167.0"},{"groupId":"OG002","value":"847.0","lowerLimit":"288.0","upperLimit":"1370.0"},{"groupId":"OG003","value":"686.0","lowerLimit":"547.0","upperLimit":"1209.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 129[N=17,26,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1044.0","lowerLimit":"910.0","upperLimit":"1252.0"},{"groupId":"OG001","value":"1129.0","lowerLimit":"796.0","upperLimit":"1399.0"},{"groupId":"OG002","value":"1074.0","lowerLimit":"688.0","upperLimit":"1881.0"},{"groupId":"OG003","value":"871.5","lowerLimit":"599.0","upperLimit":"1646.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 136[N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1621.5","lowerLimit":"913.0","upperLimit":"2476.0"},{"groupId":"OG001","value":"1279.5","lowerLimit":"875.5","upperLimit":"1426.0"},{"groupId":"OG002","value":"1594.5","lowerLimit":"1059.5","upperLimit":"3012.0"},{"groupId":"OG003","value":"1260.5","lowerLimit":"700.0","upperLimit":"2159.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 143[N=17,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1169.0","lowerLimit":"823.0","upperLimit":"1925.0"},{"groupId":"OG001","value":"1104.0","lowerLimit":"869.0","upperLimit":"1511.0"},{"groupId":"OG002","value":"1824.5","lowerLimit":"1000.5","upperLimit":"3135.5"},{"groupId":"OG003","value":"1241.0","lowerLimit":"768.0","upperLimit":"1492.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 150[N=16,26,23,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1937.0","lowerLimit":"1239.0","upperLimit":"2405.0"},{"groupId":"OG001","value":"1293.0","lowerLimit":"1101.0","upperLimit":"1435.0"},{"groupId":"OG002","value":"1967.0","lowerLimit":"1338.0","upperLimit":"3590.0"},{"groupId":"OG003","value":"989.0","lowerLimit":"766.0","upperLimit":"1721.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"2109.0","lowerLimit":"1434.0","upperLimit":"2425.0"},{"groupId":"OG001","value":"1243.0","lowerLimit":"931.0","upperLimit":"1388.0"},{"groupId":"OG002","value":"2244.0","lowerLimit":"1486.5","upperLimit":"3019.5"},{"groupId":"OG003","value":"1004.0","lowerLimit":"855.0","upperLimit":"1238.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 164[N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1692.5","lowerLimit":"1177.5","upperLimit":"2662.5"},{"groupId":"OG001","value":"1074.0","lowerLimit":"704.0","upperLimit":"1598.0"},{"groupId":"OG002","value":"2334.0","lowerLimit":"1653.0","upperLimit":"3870.0"},{"groupId":"OG003","value":"988.0","lowerLimit":"826.0","upperLimit":"1338.0"}]}]},{"title":"A/California,CD4Double TNFa,Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1250.0","lowerLimit":"975.0","upperLimit":"1864.0"},{"groupId":"OG001","value":"1063.5","lowerLimit":"841.5","upperLimit":"1532.5"},{"groupId":"OG002","value":"1581.0","lowerLimit":"983.0","upperLimit":"1833.0"},{"groupId":"OG003","value":"1027.0","lowerLimit":"750.0","upperLimit":"1345.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 125[N=14,21,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"886.0","lowerLimit":"512.0","upperLimit":"1197.0"},{"groupId":"OG001","value":"724.0","lowerLimit":"455.0","upperLimit":"883.0"},{"groupId":"OG002","value":"763.0","lowerLimit":"296.0","upperLimit":"1214.5"},{"groupId":"OG003","value":"620.0","lowerLimit":"443.0","upperLimit":"944.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 129[N=17,26,21,22]","categories":[{"measurements":[{"groupId":"OG000","value":"814.0","lowerLimit":"677.0","upperLimit":"1152.0"},{"groupId":"OG001","value":"757.5","lowerLimit":"433.0","upperLimit":"1227.0"},{"groupId":"OG002","value":"878.0","lowerLimit":"627.0","upperLimit":"1157.0"},{"groupId":"OG003","value":"755.0","lowerLimit":"519.0","upperLimit":"977.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 136[N=18,24,20,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1140.5","lowerLimit":"742.0","upperLimit":"1840.0"},{"groupId":"OG001","value":"995.0","lowerLimit":"621.5","upperLimit":"1271.5"},{"groupId":"OG002","value":"1215.5","lowerLimit":"771.5","upperLimit":"1854.5"},{"groupId":"OG003","value":"991.0","lowerLimit":"614.0","upperLimit":"1576.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 143[N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"887.5","lowerLimit":"685.0","upperLimit":"1588.0"},{"groupId":"OG001","value":"973.0","lowerLimit":"592.0","upperLimit":"1371.0"},{"groupId":"OG002","value":"1492.0","lowerLimit":"791.0","upperLimit":"2038.0"},{"groupId":"OG003","value":"938.0","lowerLimit":"627.0","upperLimit":"1242.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 150[N=16,21,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1294.0","lowerLimit":"788.5","upperLimit":"1698.5"},{"groupId":"OG001","value":"873.0","lowerLimit":"706.0","upperLimit":"1221.0"},{"groupId":"OG002","value":"1333.0","lowerLimit":"884.0","upperLimit":"2188.0"},{"groupId":"OG003","value":"836.5","lowerLimit":"498.0","upperLimit":"1390.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 157[N=17,21,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1492.0","lowerLimit":"1005.0","upperLimit":"1808.0"},{"groupId":"OG001","value":"947.0","lowerLimit":"811.0","upperLimit":"1297.0"},{"groupId":"OG002","value":"1398.5","lowerLimit":"952.0","upperLimit":"2447.0"},{"groupId":"OG003","value":"989.5","lowerLimit":"618.0","upperLimit":"1387.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 164[N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1358.0","lowerLimit":"969.5","upperLimit":"1949.0"},{"groupId":"OG001","value":"900.0","lowerLimit":"595.0","upperLimit":"1571.0"},{"groupId":"OG002","value":"1568.0","lowerLimit":"1322.0","upperLimit":"2983.0"},{"groupId":"OG003","value":"888.0","lowerLimit":"565.0","upperLimit":"1210.0"}]}]},{"title":"A/Uruguay,CD4Double TNFa,Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1136.5","lowerLimit":"885.0","upperLimit":"1526.0"},{"groupId":"OG001","value":"1078.5","lowerLimit":"689.0","upperLimit":"1353.0"},{"groupId":"OG002","value":"944.0","lowerLimit":"708.0","upperLimit":"1130.0"},{"groupId":"OG003","value":"960.0","lowerLimit":"580.0","upperLimit":"1272.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 125[N=14,22,16,17]","categories":[{"measurements":[{"groupId":"OG000","value":"922.0","lowerLimit":"563.0","upperLimit":"1555.0"},{"groupId":"OG001","value":"775.0","lowerLimit":"516.0","upperLimit":"882.0"},{"groupId":"OG002","value":"953.5","lowerLimit":"462.0","upperLimit":"1802.5"},{"groupId":"OG003","value":"690.0","lowerLimit":"507.0","upperLimit":"904.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 129[N=17,24,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"955.0","lowerLimit":"776.0","upperLimit":"1569.0"},{"groupId":"OG001","value":"869.0","lowerLimit":"608.0","upperLimit":"1184.0"},{"groupId":"OG002","value":"1077.0","lowerLimit":"369.0","upperLimit":"1617.0"},{"groupId":"OG003","value":"708.0","lowerLimit":"470.0","upperLimit":"1173.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 136[N=18,25,19,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1250.0","lowerLimit":"821.0","upperLimit":"1373.0"},{"groupId":"OG001","value":"802.0","lowerLimit":"616.0","upperLimit":"1120.0"},{"groupId":"OG002","value":"1054.0","lowerLimit":"299.0","upperLimit":"1797.0"},{"groupId":"OG003","value":"774.5","lowerLimit":"500.0","upperLimit":"1396.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 143[N=16,27,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1015.0","lowerLimit":"659.0","upperLimit":"1389.5"},{"groupId":"OG001","value":"961.0","lowerLimit":"514.0","upperLimit":"1289.0"},{"groupId":"OG002","value":"1189.5","lowerLimit":"559.5","upperLimit":"1991.5"},{"groupId":"OG003","value":"906.5","lowerLimit":"636.0","upperLimit":"1425.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 150[N=16,20,23,22]","categories":[{"measurements":[{"groupId":"OG000","value":"1175.5","lowerLimit":"580.0","upperLimit":"1468.5"},{"groupId":"OG001","value":"1044.5","lowerLimit":"715.5","upperLimit":"1347.0"},{"groupId":"OG002","value":"849.0","lowerLimit":"438.0","upperLimit":"1801.0"},{"groupId":"OG003","value":"731.0","lowerLimit":"400.0","upperLimit":"1203.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 157[N=17,22,20,18]","categories":[{"measurements":[{"groupId":"OG000","value":"1041.0","lowerLimit":"713.0","upperLimit":"1616.0"},{"groupId":"OG001","value":"965.0","lowerLimit":"635.0","upperLimit":"1312.0"},{"groupId":"OG002","value":"1156.0","lowerLimit":"462.5","upperLimit":"1655.0"},{"groupId":"OG003","value":"830.5","lowerLimit":"712.0","upperLimit":"1268.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 164[N=16,19,19,21]","categories":[{"measurements":[{"groupId":"OG000","value":"1130.5","lowerLimit":"590.0","upperLimit":"1790.5"},{"groupId":"OG001","value":"866.0","lowerLimit":"611.0","upperLimit":"1407.0"},{"groupId":"OG002","value":"1282.0","lowerLimit":"782.0","upperLimit":"2388.0"},{"groupId":"OG003","value":"849.0","lowerLimit":"455.0","upperLimit":"1132.0"}]}]},{"title":"B/Brisbane,CD4Double TNFa,Day 304[N=18,28,19,27]","categories":[{"measurements":[{"groupId":"OG000","value":"1258.5","lowerLimit":"873.0","upperLimit":"1479.0"},{"groupId":"OG001","value":"1036.5","lowerLimit":"747.5","upperLimit":"1764.5"},{"groupId":"OG002","value":"1042.0","lowerLimit":"552.0","upperLimit":"1614.0"},{"groupId":"OG003","value":"1133.0","lowerLimit":"573.0","upperLimit":"1500.0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Any and Related Potential Immune-mediated Disease (pIMDs).","description":"pIMDs are a subset of adverse events (AEs) that include both clearly autoimmune diseases and also other inflammatory and/or neurologic disorders which may or may not have an autoimmune etiology. Related = symptom assed by the investigator as causally related to the study vaccination.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"During the entire study period (up to Day 507).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"Any pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Any and Related Medically Attended Adverse Events (MAEs).","description":"MAEs refer to events that required medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (medical doctor) for any reason. Related = symptom assed by the investigator as causally related to the study vaccination.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"During the entire study period (up to Day 507).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"Any MAEs","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"4"}]}]},{"title":"Related MAEs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Unsolicited AEs.","description":"An unsolicited adverse event is any adverse event (i.e. any untoward medical occurrence in a patient or clinical investigation subject, temporally associated with use of a medicinal product, whether or not considered related to the medicinal product) reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms.\n\nUnsolicited AEs were collected after the administration of the Flulaval vaccine or the placebo dose and the data has been pooled based on the vaccination received at Day 0.","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Up to 21-day (Days 0-20) after vaccination","groups":[{"id":"OG000","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled."},{"id":"OG001","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"66"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"12"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Unsolicited AEs.","description":"Unsolicited AEs were collected after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.\n\nAn unsolicited adverse event is any adverse event (i.e. any untoward medical occurrence in a patient or clinical investigation subject, temporally associated with use of a medicinal product, whether or not considered related to the medicinal product) reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms.","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Within 84 days following first dose or 63 days following second dose of vaccine.","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"28"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"5"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Any and Related Serious Adverse Events (SAEs).","description":"SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects. Related = symptom assed by the investigator as causally related to the study vaccination.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"During the entire study period (up to Day 507).","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"Any SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Related SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Any and Related Serious Adverse Events (SAEs).","description":"SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects. Related = symptom assed by the investigator as causally related to the study vaccination. Missing values will be added once they become available.","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Up to Day 234","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"Any SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Any and Related Medically Attended Adverse Events (MAEs).","description":"MAEs refer to events that required medical attention defined as hospitalization, an emergency room visit or a visit to or from medical personnel (medical doctor) for any reason. Related = symptom assed by the investigator as causally related to the study vaccination.","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Within Days 0-233","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"Any MAEs","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"4"}]}]},{"title":"Related MAEs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Any and Related Potential Immune-mediated Disease (pIMDs).","description":"pIMDs are a subset of adverse events (AEs) that include both clearly autoimmune diseases and also other inflammatory and/or neurologic disorders which may or may not have an autoimmune etiology. Related = symptom assed by the investigator as causally related to the study vaccination.","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Within Days 0-233","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"Any pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Solicited Local Symptoms From Flulaval Group and Placebo Group.","description":"Solicited local symptoms assessed were pain, redness and swelling and data collected was pooled by administration of vaccination received at Day 0 (i.e. Flulaval or Saline placebo).\n\nAny was defined as any solicited local symptom reported irrespective of intensity. Grade 3 pain was defined as pain that prevented normal activity. Grade 3 redness and swelling were defined as redness/swelling above 100 millimeter (mm).","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination.","groups":[{"id":"OG000","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled."},{"id":"OG001","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"}]}],"classes":[{"title":"Any Pain","categories":[{"measurements":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"5"}]}]},{"title":"Grade 3 Pain","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Redness","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"}]}]},{"title":"Grade 3 Redness","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Grade 3 Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Solicited General Symptoms From Flulaval Group and Placebo Group.","description":"Solicited general symptoms assessed were fatigue, headache, joint pain at other location, muscle aches, shivering, sweating and temperature (= axillary temperature equal to or above 38.0 degrees Celsius (°C)) and data collected was pooled by administration of vaccination received at Day 0 (i.e. Flulaval or Saline placebo).\n\nAny = any solicited general symptom reported irrespective of intensity and relationship to vaccination. Related = symptoms considered by the investigator to have a causal relationship to vaccination. Grade 3 symptoms = symptoms that prevented normal activity. Grade 3 fever = axillary temperature above 39.0°C.","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination.","groups":[{"id":"OG000","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled."},{"id":"OG001","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"64"}]}],"classes":[{"title":"Any Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"7"}]}]},{"title":"Grade 3 Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"7"}]}]},{"title":"Any Headache","categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"4"}]}]},{"title":"Grade 3 Headache","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Headache","categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"3"}]}]},{"title":"Any Joint pain at other location","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"2"}]}]},{"title":"Grade 3 Joint pain at other location","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Joint pain at other location","categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"2"}]}]},{"title":"Any Muscle aches","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"3"}]}]},{"title":"Grade 3 Muscle aches","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Muscle aches","categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"3"}]}]},{"title":"Any Shivering","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"1"}]}]},{"title":"Grade 3 Shivering","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Shivering","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"1"}]}]},{"title":"Any Sweating","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"1"}]}]},{"title":"Grade 3 Sweating","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Sweating","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"1"}]}]},{"title":"Any Fever ≥ 38.0°C","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Grade 3 Fever ≥ 39.0°C","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Fever","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Solicited Local Symptoms From Flulaval/Arepanrix Group,Flulaval/Unadjuvanted Arepanrix Group,Placebo/Arepanrix Group and Placebo/Unadjuvanted Arepanrix Group","description":"Solicited local symptoms assessed were pain, redness and swelling and were collected after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.\n\nAny was defined as any solicited local symptom reported irrespective of intensity. Grade 3 pain was defined as pain that prevented normal activity. Grade 3 redness and swelling were defined as redness/swelling above 100 millimeter (mm).","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination.","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"Any Pain","categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"10"}]}]},{"title":"Grade 3 Pain","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"2"}]}]},{"title":"Any Redness","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Grade 3 Redness","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Any Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Grade 3 Swelling","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Solicited General Symptoms From Flulaval/Arepanrix Group,Flulaval/Unadjuvanted Arepanrix Group, Placebo/Arepanrix Group and Placebo/Unadjuvanted Arepanrix Group.","description":"Solicited general symptoms assessed were fatigue, headache, joint pain at other location, muscle aches, shivering, sweating and temperature (= axillary temperature equal to or above 38.0 degrees Celsius (°C)) and were collected after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.\n\nAny = any solicited general symptom reported irrespective of intensity and relationship to vaccination. Related = symptoms considered by the investigator to have a causal relationship to vaccination. Grade 3 symptoms = symptoms that prevented normal activity. Grade 3 fever = axillary temperature above 39.0°C.","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"During the 7-day (Days 0-6) follow-up period after vaccination.","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"Any Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"8"}]}]},{"title":"Grade 3 Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Related Fatigue","categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"8"}]}]},{"title":"Any Headache","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"8"}]}]},{"title":"Grade 3 Headache","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Related Headache","categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"8"}]}]},{"title":"Any Joint pain at other location","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"3"}]}]},{"title":"Grade 3 Joint pain at other location","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related Joint pain at other location","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"3"}]}]},{"title":"Any Muscle aches","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"5"}]}]},{"title":"Grade 3 Muscle aches","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related Muscle aches","categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"5"}]}]},{"title":"Any Shivering","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"0"}]}]},{"title":"Grade 3 Shivering","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related Shivering","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"0"}]}]},{"title":"Any Sweating","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"}]}]},{"title":"Grade 3 Sweating","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related Sweating","categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"}]}]},{"title":"Any Fever ≥ 38.0°C","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Grade 3 Fever ≥ 39.0°C","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Related Fever","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Haematological Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were white blood cells (WBC), neutrophils (NEU), lymphocytes (LYM), monocytes (MON), eosinophils (EOS), basophils (BAS), red blood cells (RBC), hemoglobin (Hgb), hematocrit (Hct) and platelets (PLA). For each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"On Days 0, 21, 122 and 164","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"BAS Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"28"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"27"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"27"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"33"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"30"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"EOS Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"28"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"28"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"25"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"EOS Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"22"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"3"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"29"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"31"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"3"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"28"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"25"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"26"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"2"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"20"},{"groupId":"OG003","value":"24"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hct Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hct Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hgb Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"32"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"31"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"29"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"25"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"26"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"4"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"22"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"28"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"27"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"27"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"7"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"4"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"7"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"7"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"5"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"7"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"26"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"4"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"22"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"25"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"11"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"14"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"21"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"20"},{"groupId":"OG003","value":"12"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"20"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"2"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"18"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"33"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"31"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"NEU Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"29"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"NEU Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"28"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"26"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"25"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"NEU Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"28"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"23"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"31"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"31"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"31"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"26"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"26"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"2"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"24"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Unknown, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Unknown, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Unknown, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Unknown, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Below, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Below, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Below, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Below, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Within, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"33"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"33"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Within, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"32"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"29"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC Baseline Within, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"28"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC Baseline Within, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"25"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC Baseline Above, Day 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Above, Day 21","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Above, Day 122","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Above, Day 164","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}],"categories":[{"title":"Unknown","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Below","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Within","measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]},{"title":"Above","measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Biochemistry Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), alkaline phosphatise (AP), creatinine (CREA), blood urea nitrogen (BUN) and bilirubin (BIL) (total (T) and direct (D)).\n\nFor each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"On Days 0, 21, 122 and 164","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}],"classes":[{"title":"ALAT Baseline Within-Day 0 Within (N=31,34,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"33"}]}]},{"title":"ALAT Baseline Within-Day 0 Above (N=31,34,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALAT Baseline Above-Day 0 Above (N=2,0,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALAT Baseline Within-Day 21 Unknown (N=30,34,31,32","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"ALAT Baseline Within-Day 21 Within (N=30,34,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"31"}]}]},{"title":"ALAT Baseline Above-Day 21 Above (N=2,0,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALAT Baseline Within-Day 122 Within (N=27,33,30,28","categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"27"}]}]},{"title":"ALAT Baseline Within-Day 122 Above (N=27,33,30,28)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"ALAT Baseline Above-Day 122 Above (N=2,0,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALAT Baseline Within-Day 164 Within (N=24,33,26,27","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]}]},{"title":"ALAT Baseline Within-Day 164 Above (N=24,33,26,27)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"ALAT Baseline Above-Day 164 Above (N=1,0,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AP Baseline Within-Day 0 Within (N=32,33,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}]},{"title":"AP Baseline Above-Day 0 Within (N=1,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AP Baseline Above-Day 0 Above (N=1,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AP Baseline Within-Day 21 Unknown (N=31,33,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"AP Baseline Within-Day 21 Within (N=31,33,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"31"}]}]},{"title":"AP Baseline Above-Day 21 Above (N=1,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AP Baseline Within-Day 122 Within (N=28,32,30,28)","categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"28"}]}]},{"title":"AP Baseline Above-Day 122 Above (N=1,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AP Baseline Within-Day 164 Within (N=24,32,26,27)","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"27"}]}]},{"title":"AP Baseline Above-Day 164 Above (N=1,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Unknown-Day 0 Within (N=0,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Within-Day 0 Within (N=33,33,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"33"}]}]},{"title":"ASAT Baseline Within-Day 0 Above (N=33,33,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Unknown-Day 21 Within (N=0,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Within-Day 21 Unknown (N=32,33,31,32","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"ASAT Baseline Within-Day 21 Within (N=32,33,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"31"}]}]},{"title":"ASAT Baseline Within-Day 21 Above (N=32,33,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Unknown-Day 122 Within (N=0,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Within-Day 122 Within (N=29,32,30,28","categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"28"}]}]},{"title":"ASAT Baseline Within-Day 122 Above (N=29,32,30,28)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Unknown-Day 164 Within (N=0,1,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Within-Day 164 Within (N=25,32,26,27","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]}]},{"title":"ASAT Baseline Within-Day 164 Above (N=25,32,26,27)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"BILT Baseline Within-Day 0 Within (N=32,34,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}]},{"title":"BILT Baseline Within-Day 0 Above (N=32,34,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Above-Day 0 Within (N=1,0,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Within-Day 21 Unknown (N=31,34,31,32","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BILT Baseline Within-Day 21 Within (N=31,34,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"31"}]}]},{"title":"BILT Baseline Within-Day 21 Above (N=31,34,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Above-Day 21 Within (N=1,0,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Within-Day 122 Within (N=28,33,30,28","categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"28"}]}]},{"title":"BILT Baseline Within-Day 122 Above (N=28,33,30,28)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Above-Day 122 Within (N=1,0,0,0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Within-Day 164 Within (N=25,33,26,27","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}]},{"title":"BILT Baseline Within-Day 164 Above (N=25,33,26,27)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILD Baseline Within-Day 0 Within (N=33,34,33,33)","categories":[{"measurements":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"33"},{"groupId":"OG003","value":"33"}]}]},{"title":"BILD Baseline Within-Day 21 Unknown (N=32,34,31,32","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BILD Baseline Within-Day 21 Within (N=32,34,31,32)","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"31"}]}]},{"title":"BILD Baseline Within-Day 122 Within (N=29,33,30,28","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"28"}]}]},{"title":"BILD Baseline Within-Day 164 Within (N=25,33,26,27","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"27"}]}]},{"title":"CREA Baseline Below-Day 0 Below (N=2;1;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"}]}]},{"title":"CREA Baseline Below-Day 0 Within (N=2;1;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"2"}]}]},{"title":"CREA Baseline Within-Day 0 Below (N=31;33;29;28)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"CREA Baseline Within-Day 0 Within (N=31;33;29;28)","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"26"}]}]},{"title":"CREA Baseline Below-Day 21 Below (N=2;1;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"4"}]}]},{"title":"CREA Baseline Below-Day 21 Within (N=2;1;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"CREA Baseline Within-Day 21 Unknown (N=30;33;27;27","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"CREA Baseline Within-Day 21 Below (N=30;33;27;27)","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"CREA Baseline Within-Day 21 Within (N=30;33;27;27)","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"24"}]}]},{"title":"CREA Baseline Within-Day 21 Above (N=30;33;27;27)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"CREA Baseline Below-Day 122 Below (N=2;0;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"}]}]},{"title":"CREA Baseline Below-Day 122 Within (N=2;0;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"CREA Baseline Within-Day 122 Below (N=27;33;26;23)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"CREA Baseline Within-Day 122 Within (N=27;33;26;23","categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"23"}]}]},{"title":"CREA Baseline Below-Day 164 Below (N=2;0;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"}]}]},{"title":"CREA Baseline Below-Day 164 Within (N=2;0;4;5)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"CREA Baseline Within-Day 164 Below (N=23;33;22;22)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"CREA Baseline Within-Day 164 Within (N=23;33;22;22","categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"22"}]}]},{"title":"BUN Baseline Below-Day 0 Below (N=0;0;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BUN Baseline Below-Day 0 Within (N=0;0;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"BUN Baseline Within-Day 0 Below (N=33;34;31;32)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BUN Baseline Within-Day 0 Within (N=33;34;31;32)","categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"32"}]}]},{"title":"BUN Baseline Below-Day 21 Below (N=0;0;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BUN Baseline Below-Day 21 Within (N=0;0;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"BUN Baseline Within-Day 21 Unknown (N=32;34;30;31)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BUN Baseline Within-Day 21 Below (N=32;34;30;31)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BUN Baseline Within-Day 21 Within (N=32;34;30;31)","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"30"},{"groupId":"OG003","value":"30"}]}]},{"title":"BUN Baseline Below-Day 122 Below (N=0;0;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BUN Baseline Below-Day 122 Within (N=0;0;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"BUN Baseline Within-Day 122 Within (N=29;33;29;27)","categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"29"},{"groupId":"OG003","value":"26"}]}]},{"title":"BUN Baseline Within-Day 122 Above (N=29;33;29;27)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BUN Baseline Below-Day 164 Within (N=0;0;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"BUN Baseline Within-Day 164 Below (N=25;33;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"BUN Baseline Within-Day 164 Within (N=25;33;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"25"}]}]},{"title":"BUN Baseline Within-Day 164 Above (N=25;33;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Haematological Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were white blood cells (WBC), neutrophils (NEU), lymphocytes (LYM), monocytes (MON), eosinophils (EOS), basophils (BAS), red blood cells (RBC), hemoglobin (Hgb), hematocrit (Hct) and platelets (PLA). For each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available.\n\nN (Number of participants analyzed)= number of subjects with laboratory results for the specified visit and laboratory parameter in a given baseline category Thus, there are subjects with missing results which have not been mentioned here.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"At Day 304","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"BAS Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"BAS Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"BAS Baseline Within-D304 Unknown (N=24;31;21;26)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"BAS Baseline Within-D304 Within (N=24;31;21;26)","categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"24"}]}]},{"title":"EOS Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Unknown-D304 Below (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"EOS Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Below-D304 Below (N=2;4;4;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Below-D304 Within (N=2;4;4;1)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"EOS Baseline Within-D304 Unknown (N=21;26;17;25)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"EOS Baseline Within-D304 Below (N=21;26;17;25)","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"EOS Baseline Within-D304 Within (N=21;26;17;25)","categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"22"}]}]},{"title":"EOS Baseline Above-D304 Within (N=1;1;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"EOS Baseline Above-D304 Above (N=1;1;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Unknown-D304 Below (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hct Baseline Below-D304 Below (N=1;2;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Below-D304 Within (N=1;2;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hct Baseline Within-D304 Unknown (N=23;29;19;24)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hct Baseline Within-D304 Below (N=23;29;19;24)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Within-D304 Within (N=23;29;19;24)","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"27"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"23"}]}]},{"title":"Hct Baseline Within-D304 Above (N=23;29;19;24)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Above-D304 Within (N=0;0;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hct Baseline Above-D304 Above (N=0;0;1;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hgb Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Unknown-D304 Below (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hgb Baseline Below-D304 Below (N=3;3;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"Hgb Baseline Below-D304 Within (N=3;3;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hgb Baseline Within-D304 Unknown (N=21;28;19;25)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hgb Baseline Within-D304 Below (N=21;28;19;25)","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"Hgb Baseline Within-D304 Within (N=21;28;19;25)","categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"23"}]}]},{"title":"LYM Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"LYM Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"LYM Baseline Within-D304 Unknown (N=24;31;21;26)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"LYM Baseline Within-D304 Within (N=24;31;21;26)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"24"}]}]},{"title":"LYM Baseline Within-D304 Above (N=24;31;21;26)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"MON Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"MON Baseline Below-D304 Unknown (N=3;5;5;10)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"MON Baseline Below-D304 Below (N=3;5;5;10)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"MON Baseline Below-D304 Within (N=3;5;5;10)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"7"}]}]},{"title":"MON Baseline Within-D304 Unknown (N=21;26;16;16)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"MON Baseline Within-D304 Below (N=21;26;16;16)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"MON Baseline Within-D304 Within (N=21;26;16;16)","categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"22"},{"groupId":"OG002","value":"14"},{"groupId":"OG003","value":"13"}]}]},{"title":"NEU Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"NEU Baseline Below-D304 Below (N=2;1;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Below-D304 Within (N=2;1;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"NEU Baseline Within-D304 Unknown (N=22;29;21;25)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"NEU Baseline Within-D304 Below (N=22;29;21;25)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"}]}]},{"title":"NEU Baseline Within-D304 Within (N=22;29;21;25)","categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"21"}]}]},{"title":"NEU Baseline Within-D304 Above (N=22;29;21;25)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"NEU Baseline Above-D304 Within (N=0;1;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Unknown-D304 Within (N=1;2;1;4)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"}]}]},{"title":"PLA Baseline Below-D304 Unknown (N=0;0;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"PLA Baseline Within-D304 Unknown (N=23;30;21;22)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Within-D304 Below (N=23;30;21;22)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Within-D304 Within (N=23;30;21;22)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"22"}]}]},{"title":"PLA Baseline Within-D304 Above (N=23;30;21;22)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"PLA Baseline Above-D304 Above (N=1;0;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Unknown-D304 Below (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"RBC Baseline Below-D304 Unknown (N=0;2;2;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Below-D304 Below (N=0;2;2;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Below-D304 Within (N=0;2;2;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"RBC Baseline Within-D304 Unknown (N=23;29;19;26)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"RBC Baseline Within-D304 Below (N=23;29;19;26)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Within-D304 Within (N=23;29;19;26)","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"16"},{"groupId":"OG003","value":"25"}]}]},{"title":"RBC Baseline Within-D304 Above (N=23;29;19;26)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"RBC Baseline Above-D304 Above (N=1;0;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Unknown-D304 Unknown (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Unknown-D304 Within (N=1;1;2;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC Baseline Below-D304 Below (N=0;1;2;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Below-D304 Within (N=0;1;2;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Within-D304 Unknown (N=23;28;19;25)","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC Baseline Within-D304 Below (N=23;28;19;25)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"WBC Baseline Within-D304 Within (N=23;28;19;25)","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"21"}]}]},{"title":"WBC Baseline Within-D304 Above (N=23;28;19;25)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"2"}]}]},{"title":"WBC Baseline Above-D304 Within (N=1;2;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"WBC Baseline Above-D304 Above (N=1;2;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinical Laboratory Abnormalities in Biochemistry Parameters Assessed With Respect to Normal Laboratory Ranges.","description":"Laboratory parameters assessed were alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), alkaline phosphatase (AP), creatinine (CREA), blood urea nitrogen (BUN), and bilirubin (BIL) (total (T) and direct (D)). For each parameter and for each status at baseline it was assessed whether the post-vaccination values of the parameter were above, below or within the range (unkown values are also indicated).","populationDescription":"The Total Vaccinated cohort included all vaccinated subjects for whom data were available\n\nN (Number of participants analyzed)= number of subjects with laboratory results for the specified visit and laboratory parameter in a given baseline category Thus, there are subjects with missing results which have not been mentioned here.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"At Day 304","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"ALAT Baseline Within-D304 Within (N=24;32;23;26)","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"26"}]}]},{"title":"ALAT Baseline Within-D304 Above (N=24;32;23;26)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ALAT Baseline Above-D304 Within (N=1;0;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"AP Baseline Within-D304 Within (N=24;30;22;27)","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"}]}]},{"title":"AP Baseline Within-D304 Above (N=24;30;22;27)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"AP Baseline Above-D304 Within (N=1;1;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"AP Baseline Above-D304 Above (N=1;1;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Within-D304 Within (N=24;32;23;27)","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"27"}]}]},{"title":"ASAT Baseline Within-D304 Above (N=24;32;23;27)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ASAT Baseline Above-D304 Within (N=1;0;0;0)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Within-D304 Within (N=25;31;22;27)","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"27"}]}]},{"title":"BILT Baseline Within-D304 Above (N=25;31;22;27)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Above-D304 Within (N=0;1;1;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILT Baseline Above-D304 Above (N=0;1;1;0)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"BILD Baseline Within-D304 Within (N=25;32;23;27)","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"27"}]}]},{"title":"BILD Baseline Within-D304 Above (N=25;32;23;27)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"CREA Baseline Below-D304 Below (N=2;0;2;5)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"2"}]}]},{"title":"CREA Baseline Below-D304 Within (N=2;0;2;5)","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"3"}]}]},{"title":"CREA Baseline Within-D304 Below (N=23;31;20;22)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"}]}]},{"title":"CREA Baseline Within-D304 Within (N=23;31;20;22)","categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"21"}]}]},{"title":"BUN Baseline Below-D304 Below (N=0;0;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]},{"title":"BUN Baseline Within-D304 Within (N=25;31;22;25)","categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"25"}]}]},{"title":"BUN Baseline Above-D304 Within (N=0;0;0;1)","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.\n\nSeropositivity rates of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14 and 21 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122","groups":[{"id":"OG000","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled."},{"id":"OG001","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"52"}]}],"classes":[{"title":">= 1:10 Flu A/CAL/7/09 H1N1 pre-vaccination","categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"26"}]}]},{"title":">= 1:10 Flu A/CAL/7/09 H1N1 Day 7","categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"25"}]}]},{"title":">= 1:10 Flu A/CAL/7/09 H1N1 Day 14","categories":[{"measurements":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"26"}]}]},{"title":">= 1:10 Flu A/CAL/7/09 H1N1 Day 21","categories":[{"measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"26"}]}]},{"title":">= 1:10 Flu A/CAL/7/09 H1N1 Day 122","categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"26"}]}]}]},{"type":"SECONDARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs). GMTs of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14, 21 and 122 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122","groups":[{"id":"OG000","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled."},{"id":"OG001","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"52"}]}],"classes":[{"title":"GMT Flu A/CAL/7/09 H1N1 pre-vaccination","categories":[{"measurements":[{"groupId":"OG000","value":"12.5","lowerLimit":"8.6","upperLimit":"18.2"},{"groupId":"OG001","value":"13.9","lowerLimit":"9.6","upperLimit":"20.1"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 7","categories":[{"measurements":[{"groupId":"OG000","value":"14.8","lowerLimit":"10.2","upperLimit":"21.5"},{"groupId":"OG001","value":"13.8","lowerLimit":"9.6","upperLimit":"20.0"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 14","categories":[{"measurements":[{"groupId":"OG000","value":"19.9","lowerLimit":"13.7","upperLimit":"28.7"},{"groupId":"OG001","value":"13.8","lowerLimit":"9.6","upperLimit":"19.9"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 21","categories":[{"measurements":[{"groupId":"OG000","value":"17.8","lowerLimit":"12.4","upperLimit":"25.6"},{"groupId":"OG001","value":"13.3","lowerLimit":"9.3","upperLimit":"19.0"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 122","categories":[{"measurements":[{"groupId":"OG000","value":"13.8","lowerLimit":"9.6","upperLimit":"19.8"},{"groupId":"OG001","value":"13.4","lowerLimit":"9.5","upperLimit":"18.9"}]}]}]},{"type":"SECONDARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164.","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":">= 1:10 A/CAL/7/09 H1N1 Day 122 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"13"},{"groupId":"OG003","value":"13"}]}]},{"title":">= 1:10 A/CAL/7/09 H1N1 Day 129 (N=21;31;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"23"}]}]},{"title":">= 1:10 A/CAL/7/09 H1N1 Day 136 (N=21;33;23;26)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"26"}]}]},{"title":">= 1:10 A/CAL/7/09 H1N1 Day 143 (N=21;33;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]}]},{"title":">= 1:10 A/CAL/7/09 H1N1 Day 150 (N=19;31;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]}]},{"title":">= 1:10 A/CAL/7/09 H1N1 Day 157 (N=20;32;24;25)","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"25"}]}]},{"title":">= 1:10 A/CAL/7/09 H1N1 Day 164 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}]}]},{"type":"SECONDARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/California/7/2009 (H1N1)V-like Virus-homologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164.","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"GMT Flu A/CAL/7/09 H1N1 Day 122 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"16.1","lowerLimit":"8.9","upperLimit":"29.3"},{"groupId":"OG001","value":"12.5","lowerLimit":"7.7","upperLimit":"20.1"},{"groupId":"OG002","value":"13.9","lowerLimit":"8.1","upperLimit":"24.0"},{"groupId":"OG003","value":"12.9","lowerLimit":"8.1","upperLimit":"20.7"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 129 (N=21;31;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"66.7","lowerLimit":"35.7","upperLimit":"124.6"},{"groupId":"OG001","value":"54.6","lowerLimit":"28.7","upperLimit":"103.9"},{"groupId":"OG002","value":"83.3","lowerLimit":"44.2","upperLimit":"157.3"},{"groupId":"OG003","value":"70.3","lowerLimit":"38.8","upperLimit":"127.6"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 136 (N=21;33;23;26)","categories":[{"measurements":[{"groupId":"OG000","value":"491.6","lowerLimit":"319.3","upperLimit":"756.9"},{"groupId":"OG001","value":"303.7","lowerLimit":"191.7","upperLimit":"481.0"},{"groupId":"OG002","value":"602.5","lowerLimit":"434.1","upperLimit":"836.4"},{"groupId":"OG003","value":"385.6","lowerLimit":"242.9","upperLimit":"612.1"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 143 (N=21;33;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"390.1","lowerLimit":"266.3","upperLimit":"571.5"},{"groupId":"OG001","value":"256.6","lowerLimit":"164.9","upperLimit":"399.3"},{"groupId":"OG002","value":"557.3","lowerLimit":"426.5","upperLimit":"728.3"},{"groupId":"OG003","value":"365.6","lowerLimit":"241.3","upperLimit":"553.9"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 150 (N=19;31;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"452.8","lowerLimit":"305.6","upperLimit":"670.9"},{"groupId":"OG001","value":"292.7","lowerLimit":"198.0","upperLimit":"432.7"},{"groupId":"OG002","value":"565.0","lowerLimit":"423.3","upperLimit":"754.1"},{"groupId":"OG003","value":"333.3","lowerLimit":"220.8","upperLimit":"503.0"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 157 (N=20;32;24;25)","categories":[{"measurements":[{"groupId":"OG000","value":"651.3","lowerLimit":"487.1","upperLimit":"870.8"},{"groupId":"OG001","value":"303.2","lowerLimit":"215.1","upperLimit":"427.4"},{"groupId":"OG002","value":"818.1","lowerLimit":"634.9","upperLimit":"1054.0"},{"groupId":"OG003","value":"338.2","lowerLimit":"230.7","upperLimit":"495.7"}]}]},{"title":"GMT Flu A/CAL/7/09 H1N1 Day 164 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"650.7","lowerLimit":"485.5","upperLimit":"872.1"},{"groupId":"OG001","value":"259.4","lowerLimit":"186.4","upperLimit":"361.0"},{"groupId":"OG002","value":"799.0","lowerLimit":"630.5","upperLimit":"1012.4"},{"groupId":"OG003","value":"332.7","lowerLimit":"222.0","upperLimit":"498.6"}]}]}]},{"type":"SECONDARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.\n\nSeropositivity rates of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14, 21 and 122 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122","groups":[{"id":"OG000","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled."},{"id":"OG001","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"52"}]}],"classes":[{"title":">= 1:10 Flu A/BRI/59/07 H1N1 Pre-vaccination","categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"44"}]}]},{"title":">= 1:10 Flu A/BRI/59/07 H1N1 Day 7","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"}]}]},{"title":">= 1:10 Flu A/BRI/59/07 H1N1 Day 14","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"44"}]}]},{"title":">= 1:10 Flu A/BRI/59/07 H1N1 Day 21","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"44"}]}]},{"title":">= 1:10 Flu A/BRI/59/07 H1N1 Day 122","categories":[{"measurements":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"46"}]}]}]},{"type":"SECONDARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs). GMTs of H1N1 HI antibody titers in terms of humoral immune response was pooled by the vaccination received at Day 0 (i.e. Flulaval or Saline placebo) at Days 7, 14, 21 and 122 upto the administration of the first dose of Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"Before vaccination and at Days 7, 14, 21 and 122","groups":[{"id":"OG000","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled."},{"id":"OG001","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"52"}]}],"classes":[{"title":"GMT Flu A/BRI/59/07 H1N1 pre-vaccination","categories":[{"measurements":[{"groupId":"OG000","value":"23.3","lowerLimit":"17.7","upperLimit":"30.5"},{"groupId":"OG001","value":"18.7","lowerLimit":"14.6","upperLimit":"23.9"}]}]},{"title":"GMT Flu A/BRI/59/07 H1N1 Day 7","categories":[{"measurements":[{"groupId":"OG000","value":"65.5","lowerLimit":"47.4","upperLimit":"90.6"},{"groupId":"OG001","value":"18.3","lowerLimit":"14.4","upperLimit":"23.3"}]}]},{"title":"GMT Flu A/BRI/59/07 H1N1 Day 14","categories":[{"measurements":[{"groupId":"OG000","value":"213.6","lowerLimit":"153.0","upperLimit":"298.2"},{"groupId":"OG001","value":"18.4","lowerLimit":"14.2","upperLimit":"23.8"}]}]},{"title":"GMT Flu A/BRI/59/07 H1N1 Day 21","categories":[{"measurements":[{"groupId":"OG000","value":"200.3","lowerLimit":"146.0","upperLimit":"274.8"},{"groupId":"OG001","value":"18.8","lowerLimit":"14.6","upperLimit":"24.1"}]}]},{"title":"GMT Flu A/BRI/59/07 H1N1 Day 122","categories":[{"measurements":[{"groupId":"OG000","value":"129.4","lowerLimit":"97.6","upperLimit":"171.6"},{"groupId":"OG001","value":"18.1","lowerLimit":"14.3","upperLimit":"23.1"}]}]}]},{"type":"SECONDARY","title":"Number of Seropositive Subjects for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"A seropositive subject was a subject whose HI antibody titer was greater than or equal to the assay cut-off value of 1:10.","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Subjects","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164.","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":">= 1:10 A/BRI/59/07 H1N1 Day 122 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"24"}]}]},{"title":">= 1:10 A/BRI/59/07 H1N1 Day 129 (N=21;31;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]}]},{"title":">= 1:10 A/BRI/59/07 H1N1 Day 136 (N=21;33;23;26)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"26"}]}]},{"title":">= 1:10 A/BRI/59/07 H1N1 Day 143 (N=21;33;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"25"}]}]},{"title":">= 1:10 A/BRI/59/07 H1N1 Day 150 (N=19;31;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"26"}]}]},{"title":">= 1:10 A/BRI/59/07 H1N1 Day 157 (N=20;32;24;25)","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"25"}]}]},{"title":">= 1:10 A/BRI/59/07 H1N1 Day 164 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"27"}]}]}]},{"type":"SECONDARY","title":"Titers for Hemagglutination Inhibition (HI) Antibodies Against A/Brisbane/59/2007 (H1N1) Virus-heterologous Vaccine Strain.","description":"Titers were expressed as geometric mean antibody titers (GMTs).","populationDescription":"The According-To-Protocol cohort for immunogenicity at Day 164 included subjects who had not received a vaccine not specified in the protocol during the primary vaccination course, for whom 3 doses were administered and assay results were available for antibodies against H1N1 antigen at day 21 after the second H1N1 vaccine dose (Day 164).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Titers","timeFrame":"At Days 122, 129, 136, 143, 150, 157 and 164.","groups":[{"id":"OG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."},{"id":"OG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"33"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"27"}]}],"classes":[{"title":"GMT A/BRI/59/07 H1N1 Day 122 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"135.6","lowerLimit":"87.5","upperLimit":"209.9"},{"groupId":"OG001","value":"125.7","lowerLimit":"85.3","upperLimit":"185.0"},{"groupId":"OG002","value":"18.4","lowerLimit":"13.5","upperLimit":"25.0"},{"groupId":"OG003","value":"18.0","lowerLimit":"12.2","upperLimit":"26.4"}]}]},{"title":"GMT A/BRI/59/07 H1N1 Day 129 (N=21;31;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"140.4","lowerLimit":"86.9","upperLimit":"226.7"},{"groupId":"OG001","value":"126.5","lowerLimit":"85.6","upperLimit":"186.9"},{"groupId":"OG002","value":"27.0","lowerLimit":"20.6","upperLimit":"35.4"},{"groupId":"OG003","value":"24.4","lowerLimit":"17.9","upperLimit":"33.3"}]}]},{"title":"GMT A/BRI/59/07 H1N1 Day 136 (N=21;33;23;26)","categories":[{"measurements":[{"groupId":"OG000","value":"144.9","lowerLimit":"90.0","upperLimit":"233.4"},{"groupId":"OG001","value":"144.1","lowerLimit":"98.0","upperLimit":"211.9"},{"groupId":"OG002","value":"44.4","lowerLimit":"32.2","upperLimit":"61.2"},{"groupId":"OG003","value":"38.9","lowerLimit":"26.5","upperLimit":"57.2"}]}]},{"title":"GMT A/BRI/59/07 H1N1 Day 143 (N=21;33;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"140.3","lowerLimit":"91.5","upperLimit":"215.1"},{"groupId":"OG001","value":"129.6","lowerLimit":"88.9","upperLimit":"189.1"},{"groupId":"OG002","value":"38.8","lowerLimit":"29.1","upperLimit":"51.7"},{"groupId":"OG003","value":"35.4","lowerLimit":"23.9","upperLimit":"52.3"}]}]},{"title":"GMT A/BRI/59/07 H1N1 Day 150 (N=19;31;25;26)","categories":[{"measurements":[{"groupId":"OG000","value":"146.1","lowerLimit":"91.2","upperLimit":"234.2"},{"groupId":"OG001","value":"138.2","lowerLimit":"93.5","upperLimit":"204.1"},{"groupId":"OG002","value":"44.0","lowerLimit":"33.0","upperLimit":"58.8"},{"groupId":"OG003","value":"34.5","lowerLimit":"24.5","upperLimit":"48.5"}]}]},{"title":"GMT A/BRI/59/07 H1N1 Day 157 (N=20;32;24;25)","categories":[{"measurements":[{"groupId":"OG000","value":"144.2","lowerLimit":"93.4","upperLimit":"222.7"},{"groupId":"OG001","value":"131.5","lowerLimit":"89.1","upperLimit":"194.1"},{"groupId":"OG002","value":"49.6","lowerLimit":"35.9","upperLimit":"68.6"},{"groupId":"OG003","value":"33.8","lowerLimit":"24.1","upperLimit":"47.5"}]}]},{"title":"GMT A/BRI/59/07 H1N1 Day 164 (N=21;33;25;27)","categories":[{"measurements":[{"groupId":"OG000","value":"144.9","lowerLimit":"97.2","upperLimit":"216.1"},{"groupId":"OG001","value":"123.1","lowerLimit":"87.1","upperLimit":"174.0"},{"groupId":"OG002","value":"49.2","lowerLimit":"33.9","upperLimit":"71.2"},{"groupId":"OG003","value":"35.2","lowerLimit":"25.7","upperLimit":"48.2"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"SAEs: During the entire study period (up to Day 507). Solicited AEs: During a 7-day follow-up period after administration of vaccine. Unsolicted AEs: Up to 21days (Days 0-20) after vaccination and within 84 days after dose 1 or 63 days after dose 2.","description":"Even though all subjects reporting solicited and unsolicited AEs were analysed, no subjects reported unsolicited AEs which was equal to or above the 5% frequency threshold.","eventGroups":[{"id":"EG000","title":"Flulaval/Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","seriousNumAffected":3,"seriousNumAtRisk":33,"otherNumAffected":24,"otherNumAtRisk":33},{"id":"EG001","title":"Flulaval/Unadjuvanted Arepanrix Group","description":"subjects received Flulaval vaccine on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","seriousNumAffected":1,"seriousNumAtRisk":34,"otherNumAffected":25,"otherNumAtRisk":34},{"id":"EG002","title":"Placebo/Arepanrix Group","description":"subjects received a saline placebo on Day 0 and Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","seriousNumAffected":1,"seriousNumAtRisk":33,"otherNumAffected":27,"otherNumAtRisk":33},{"id":"EG003","title":"Placebo/Unadjuvanted Arepanrix Group","description":"subjects received a saline placebo on Day 0 and the unadjuvanted formulation of Arepanrix vaccine on Day 122 and Day 143. All vaccines were given intramuscularly, in the deltoid region of the non-dominant arm at Days 0 and 122 and of the dominant arm at Day 143.","seriousNumAffected":1,"seriousNumAtRisk":33,"otherNumAffected":17,"otherNumAtRisk":33},{"id":"EG004","title":"Flulaval Group","description":"subjects from the Flulaval/Arepanrix Group and the Flulaval/Unadjuvanted Arepanrix Group were pooled.","seriousNumAffected":0,"seriousNumAtRisk":0,"otherNumAffected":44,"otherNumAtRisk":67},{"id":"EG005","title":"Placebo Group","description":"subjects from the Placebo/Arepanrix Group and the Placebo/Unadjuvanted Arepanrix Group were pooled.","seriousNumAffected":0,"seriousNumAtRisk":0,"otherNumAffected":19,"otherNumAtRisk":66}],"seriousEvents":[{"term":"Aortic aneurysm","organSystem":"Vascular disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":0},{"groupId":"EG005","numAffected":0,"numAtRisk":0}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":1,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":0},{"groupId":"EG005","numAffected":0,"numAtRisk":0}]},{"term":"Clostridial infection","organSystem":"Infections and infestations","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":1,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":0},{"groupId":"EG005","numAffected":0,"numAtRisk":0}]},{"term":"Hepatitis C","organSystem":"Infections and infestations","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":0},{"groupId":"EG005","numAffected":0,"numAtRisk":0}]},{"term":"Liver function test abnormal","organSystem":"Investigations","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":1,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":0},{"groupId":"EG005","numAffected":0,"numAtRisk":0}]},{"term":"Uterine leiomyoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":0},{"groupId":"EG005","numAffected":0,"numAtRisk":0}]}],"otherEvents":[{"term":"Pain","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited local symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":35,"numAtRisk":67},{"groupId":"EG005","numAffected":5,"numAtRisk":66}]},{"term":"Fatigue","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":18,"numAtRisk":67},{"groupId":"EG005","numAffected":7,"numAtRisk":66}]},{"term":"Headache","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":19,"numAtRisk":67},{"groupId":"EG005","numAffected":4,"numAtRisk":66}]},{"term":"Joint pain at other location","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":13,"numAtRisk":67},{"groupId":"EG005","numAffected":2,"numAtRisk":66}]},{"term":"Muscle aches","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":20,"numAtRisk":67},{"groupId":"EG005","numAffected":3,"numAtRisk":66}]},{"term":"Shivering","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":8,"numAtRisk":67},{"groupId":"EG005","numAffected":1,"numAtRisk":66}]},{"term":"Sweating","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":9,"numAtRisk":67},{"groupId":"EG005","numAffected":1,"numAtRisk":66}]},{"term":"Pain","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited local symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":33},{"groupId":"EG001","numAffected":14,"numAtRisk":34},{"groupId":"EG002","numAffected":24,"numAtRisk":33},{"groupId":"EG003","numAffected":10,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Swelling","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited local symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":33},{"groupId":"EG001","numAffected":1,"numAtRisk":34},{"groupId":"EG002","numAffected":2,"numAtRisk":33},{"groupId":"EG003","numAffected":1,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Fatigue","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":33},{"groupId":"EG001","numAffected":13,"numAtRisk":34},{"groupId":"EG002","numAffected":12,"numAtRisk":33},{"groupId":"EG003","numAffected":8,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Headache","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":33},{"groupId":"EG001","numAffected":11,"numAtRisk":34},{"groupId":"EG002","numAffected":9,"numAtRisk":33},{"groupId":"EG003","numAffected":8,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Joint pain at other location","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":33},{"groupId":"EG001","numAffected":2,"numAtRisk":34},{"groupId":"EG002","numAffected":9,"numAtRisk":33},{"groupId":"EG003","numAffected":3,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Muscle aches","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":33},{"groupId":"EG001","numAffected":12,"numAtRisk":34},{"groupId":"EG002","numAffected":12,"numAtRisk":33},{"groupId":"EG003","numAffected":5,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Redness","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited local symptom reported during the 7-day (Days 0-6) after the administration of the Flulaval or Placebo dose.","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":33},{"groupId":"EG001","numAffected":0,"numAtRisk":34},{"groupId":"EG002","numAffected":0,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":4,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Shivering","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":33},{"groupId":"EG001","numAffected":2,"numAtRisk":34},{"groupId":"EG002","numAffected":5,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]},{"term":"Sweating","organSystem":"General disorders","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"Solicited general symptom reported during the 7-day (Days 0-6) after the administration of the Arepanrix or the unadjuvanted formulation of Arepanrix vaccine.","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":33},{"groupId":"EG001","numAffected":4,"numAtRisk":34},{"groupId":"EG002","numAffected":4,"numAtRisk":33},{"groupId":"EG003","numAffected":0,"numAtRisk":33},{"groupId":"EG004","numAffected":0,"numAtRisk":67},{"groupId":"EG005","numAffected":0,"numAtRisk":66}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","phone":"866-435-7343"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D007251","term":"Influenza, Human"}],"ancestors":[{"id":"D012141","term":"Respiratory Tract Infections"},{"id":"D007239","term":"Infections"},{"id":"D009976","term":"Orthomyxoviridae Infections"},{"id":"D012327","term":"RNA Virus Infections"},{"id":"D014777","term":"Virus Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D012965","term":"Sodium Chloride"}],"ancestors":[{"id":"D002712","term":"Chlorides"},{"id":"D006851","term":"Hydrochloric Acid"},{"id":"D017606","term":"Chlorine Compounds"},{"id":"D007287","term":"Inorganic Chemicals"},{"id":"D017670","term":"Sodium Compounds"}]}},"hasResults":true}